| Excerpt | Reference |
|---|
| "Finally, multiple substance use is not predominant among marijuana users, but is predominant among users of other substances." | ( Babst, DV; Bergman, PJ; Dembo, R; Diamond, SC; Lipton, DS; Schmeidler, J; Speilman, CR; Stephens, RC; Uppal, GS, 1977) |
| "Vulnerability to substance abuse is an important social and scientific issue." | ( George, FR; Ritz, MC, 1991) |
| "Vulnerability to substance abuse is an important emerging issue." | ( George, FR, 1991) |
| "Perinatal substance abuse is independently associated with growth retardation and prematurity." | ( Batra, KK; Evans, AT; Gillogley, KM; Hansen, RL; Samuels, SJ, 1990) |
| "Drug abuse is continuing to change the field of health care." | ( Amble, FR, 1990) |
| "Drug abuse is not generally a problem among cancer patients with pain." | ( Hill, CS, 1989) |
| "The effects of drug abuse are caused by the stimulation or inhibition of different neurotransmitters, chiefly gamma-aminobutyric acid, acetylcholine, norepinephrine, dopamine, serotonin and beta-endorphin." | ( Giannini, AJ; Miller, NS, 1989) |
| "1." | ( Anderson, HR; Bloor, K; Flanagan, RJ; Ramsey, J, 1989) |
| "Substance abuse is a significant health problem in the adolescent population." | ( Kulberg, A, 1986) |
| "When chemical dependence is identified, detoxification may be all that is necessary." | ( Kranzler, HR; Liebowitz, NR, 1988) |
| "Alcohol and drug addiction are defined in behavioral terms as the preoccupation with, compulsive use of, and relapse to drugs that are descriptive and confirmatory." | ( Dackis, CA; Gold, MS; Miller, NS, 1987) |
| "Parenteral substance abuse is widespread." | ( Williams, A, 1986) |
| "Yet chemical dependence is believed to be a leading occupational hazard for physicians." | ( Gallegos, KV; Porter, TL; Talbott, GD; Wilson, PO, 1987) |
| "Intravenous (IV) drug abuse is known to cause pulmonary tale granulomatosis." | ( Hudson, LD; Pierson, DJ; Sherman, CB, 1987) |
| "Drug abuse is a prevalent problem in society and often occurs as abuse of multiple substances." | ( Ahmed, I; Kulick, AR, 1986) |
| "While alcohol and drug abuse are widely prevalent among adolescents, screening for drug and alcohol use, abuse, and risk factors is not a routine practice in primary care pediatrics." | ( Blasinsky, M; Gruenewald, P; Klitzner, M; Schwartz, RH, 1987) |
| "The consequences of drug abuse are not as well documented, but recent survey data from Indian school students point to an extremely serious situation." | ( Beauvais, F; LaBoueff, S, 1985) |
| "Drug dependence is due less to intrinsic effects than to the situation in which drug taking occurs." | ( Falk, JL, 1983) |
| "While substance abuse is less prevalent in the elderly than in younger cohorts, it is common enough to constitute a significant public health problem, may increase in the future, is often overlooked by clinicians, and may be successfully managed if treatment is tailored to the special requirements of this age group." | ( Atkinson, RM; Kofoed, LL, 1982) |
| "Substance abuse is associated diagnostically with existing depression, pathological mourning of the traumatic event itself, with the inevitable experience of object loss, and loss of love." | ( Miller, JR, 1994) |
| "Chemical dependence is a devastating disease that, unless some form of intervention and treatment takes place, will ultimately destroy a person's life." | ( Jessee, SA, 1993) |
| "Substance abuse is a serious problem in the young adult population, yet there exists a lack of reliable screening measures for use in identifying problem users in this age group." | ( Bennett, ME; Frankenstein, W; Keller, DS; Laitman, LA; McCrady, BS; Van Horn, DH, 1993) |
| "This drug abuse is rarely reported spontaneously." | ( Korten, JJ; Roebroek, RM, 1996) |
| "National trends in substance abuse are presented: the civilian noninstitutionalized general population; drug-related emergency department episodes; and booked arrestees." | ( Rouse, BA, 1996) |
| "Drug abuse is a major public health problem, and the relationship between intravenous drug abuse and AIDS underscores the need for more effective treatment medications." | ( Mello, NK; Negus, SS, 1996) |
| "Alcohol and other substance use disorders are highly comorbid." | ( Clifford, PR; Earleywine, M; Kirisci, L; Longabaugh, R; Maisto, SA; Martin, CS, 1996) |
| "Substance abuse is a significant risk factor for HIV in pregnancy." | ( Sprauve, ME, 1996) |
| "Drug addiction is considered in terms of an addiction syndrome, and a theory for its motivation is proposed, based on the treatment of several drug addicts in psychoanalysis and psychotherapy." | ( Hopper, E, 1995) |
| "A history of substance abuse is considered by many to be a contraindication to chronic opioid therapy for nonmalignant pain." | ( Dunbar, SA; Katz, NP, 1996) |
| "The therapy of the drug addiction is divided into the stages of contact, detoxification, weaning, and aftercare." | ( Täschner, KL, 1996) |
| "Severity of drug dependence is inversely related to severity of alcohol dependence among Whites." | ( Caetano, R; Schafer, J, 1996) |
| "Substance use is common in pregnant adolescents from all ethnic and economic backgrounds." | ( Anderson, MM; Archie, CL; Gruber, EL, 1997) |
| "Volatile substance abuse is practised worldwide however reports of the abuse of leaded gasoline have been limited to northern Canada, southwestern USA and the Australian Outback." | ( Tenenbein, M, 1997) |
| "Oral drug abuse is a major social and medical issue." | ( Crawford, PJ; Fisher, BM, 1997) |
| "Substance abuse is well documented among bodybuilders and weight lifters keen to enhance their performance." | ( FitzSimmons, CR; Kidner, N, 1998) |
| "Drug addiction is characterized by motivational disturbances such as compulsive drug taking and episodes of intense drug craving." | ( Self, DW, 1998) |
| "The prevalence of substance abuse is elevated among schizophrenic patients." | ( D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL, 1999) |
| "The subject of 'drug addiction' is multifaceted and many aspects of it (even some of the definitions) are controversial." | ( Betz, C; Mihalic, D; Pinto, ME; Raffa, RB, 2000) |
| "The risk of drug dependence is lower with the benzomorphans, which usually act as partial agonists at the mu opioid receptor and as kappa agonists." | ( Bidlack, JM; McLaughlin, JP; Wentland, MP, 2000) |
| "Drug abuse is a common method of human immunodeficiency virus type 1 transmission, but the role of opiates on lentivirus disease progression is not well understood." | ( Barr, MC; Billaud, JN; Henriksen, SJ; Huitron-Resendiz, S; Osborn, KG; Phillips, TR; Selway, DR, 2000) |
| "Substance abuse is a common comorbid illness in patients with mood disorders." | ( Albanese, MJ; Clodfelter, RC; Khantzian, EJ, 2000) |
| "Substance abuse (chemical dependence) is often a silent, but pervasive problem in today's society." | ( Byrd, PB, 2001) |
| "Volatile substance abuse is practiced mainly by adolescents and young adults." | ( Baum, Y; Bentur, Y; Hoffer, E; Raikhlin-Eisenkraft, B, 2001) |
| "Drug dependence is developed by repeated administration of addictive drugs." | ( Miki, N, 2001) |
| "Chronic drug abuse is an established cause of acute coronary events and sudden death." | ( Callahan, KP; Malinin, AI; Serebruany, VL, 2001) |
| "A new theory of substance use disorders is proposed-the SPFit theory-that is based on evolutionary biology and adaptive systems." | ( Newlin, DB, 2002) |
| "This form of substance abuse is widespread throughout the world and usually popular among secondary school children and young adults because of its easy availability and it is cheaper compared with most drugs of abuse." | ( Razak, M; Zabedah, MY; Zakiah, I; Zuraidah, AB, 2001) |
| "Drug addiction is characterized by a set of recurring processes (intoxication, withdrawal, craving) that lead to the relapsing nature of the disorder." | ( Fowler, JS; Goldstein, RZ; Volkow, ND; Wang, GJ, 2002) |
| "Drug dependence is one of most severe problems in all over the world, however, the mechanisms and related-genes have not been completely revealed." | ( Nabeshima, T; Nakajima, A; Nitta, A; Noda, Y; Yamada, K; Yamada, Y, 2003) |
| "Drug addiction is a chronic relapsing disorder characterized by compulsive drug intake, loss of control over intake, and impairment in social and occupational function." | ( Ahmed, SH; Boutrel, B; Chen, SA; Kenny, PJ; Koob, GF; Markou, A; O'Dell, LE; Parsons, LH; Sanna, PP, 2004) |
| "Drug abuse is a global problem of considerable concern to health." | ( Connor, TJ, 2004) |
| "Volatile substance abuse is reported throughout the U." | ( Spiller, HA, 2004) |
| "Substance use disorders are the nation's number one health problem, and lie at the root of many public safety and workplace issues." | ( , 2004) |
| "Drug addiction is recognized as a mental disease affecting the brain's natural reward system." | ( Caron, MG; Mohn, AR; Yao, WD, 2004) |
| "Substance use disorders are an important public health problem associated with significant mortality and morbidity." | ( Kosten, TR; Sofuoglu, M, 2004) |
| "Substance use disorders are familial, and genetic factors explain a substantial degree of their familial aggregation." | ( Ball, DM; Chen, CK; Hu, X; Li, T; Lin, SK; Loh, el-W; Murray, RM; Sham, PC, 2004) |
| "Substance abuse is extremely common in patients with bipolar disorders, although minimal data are available on the treatment of this important clinical population." | ( Beard, L; Brown, ES; Garza, M; Jeffress, J; Liggin, JD, 2005) |
| "An increase in polydrug abuse is a major problem worldwide." | ( Ito, S; Mori, T; Namiki, M; Sawaguchi, T; Suzuki, T, 2005) |
| "Drug addiction is increasingly viewed as the endpoint of a series of transitions from initial drug use--when a drug is voluntarily taken because it has reinforcing, often hedonic, effects--through loss of control over this behavior, such that it becomes habitual and ultimately compulsive." | ( Everitt, BJ; Robbins, TW, 2005) |
| "Drug addiction is a chronic disease characterized by compulsive drug use despite the severe negative consequences associated with it." | ( Jurd, R; Ron, D, 2005) |
| "Patients with drug use disorders are heavy users of emergency department (ED) and inpatient hospital care." | ( Friedmann, PD; Gerstein, DR; Hendrickson, JC; Stein, MD; Zhang, Z, 2006) |
| "Drug dependence is a chronically relapsing disorder, manifested as an intense desire for the drug, with impaired ability to control the urges to take the drug, even at the expense of serious adverse consequences." | ( Parolaro, D; Rubino, T; Viganò, D, 2005) |
| "Prenatal substance abuse is an ongoing concern with significant impact on neonatal health and development across socioeconomic lines." | ( Gareri, J; Klein, J; Koren, G, 2006) |
| "Detoxification from drug abuse is strongly threatened by the occurrence of renewed episodes of drug intake." | ( Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Melis, V; Spano, MS, 2007) |
| "Drug abuse is a widespread problem across society, and its negative impact on performance and safety in the workplace cannot be overstated." | ( Cone, EJ, 2006) |
| "Drug abuse is hazardous and known to be prevalent among young adults, warranting efforts to increase awareness about harmful effects and to change attitudes." | ( Naqvi, H; Salahuddin, FF; Saleem, A; Shafiq, M; Shah, Z; Shaikh, KS; Siddiqi, MT; Siwani, R, 2006) |
| "Alcohol and illicit drug abuse is a serious problem among male Latino gang members." | ( De La Rosa, M; Rice, C; Rugh, D, 2006) |
| "Substance use disorders are common in patients taking opioids for back pain, and aberrant medication-taking behaviors occur in up to 24% of cases." | ( Becker, WC; Fiellin, DA; Kerns, RD; Kosten, TR; Martell, BA; Morales, KH; O'Connor, PG, 2007) |
| "Substance abuse is a frequent comorbid condition with other psychiatric disorders including schizophrenia and depression." | ( Archer, T; Beninger, RJ; Kostrzewa, RM; Palomo, T, 2007) |
| "Drug addiction is a complex problem which leads to many somatic, psychic and social diseases." | ( Brodowska, A; Brodowski, J; Chlubek, D; Karakiewicz, B; Kozielec, T; Laszczyńska, M; Noceń, I; Starczewski, A, 2007) |
| "A challenge in drug dependence is to delineate long-term behavioral and neurochemical modifications induced by drugs of abuse." | ( Tassin, JP, 2008) |
| "Drug addiction is a chronic, relapsing disorder, characterized by an uncontrollable motivation to seek and use drugs." | ( Ary, AW; Lominac, KD; Szumlinski, KK, 2008) |
| "A challenge in drug dependence is to delineate long-term neurochemical modifications induced by drugs of abuse." | ( Glowinski, J; Lanteri, C; Salomon, L; Tassin, JP; Torrens, Y, 2008) |
| "Drug addiction is a chronic relapsing disease in which drug administration becomes the primary stimulus that drives behavior regardless of the adverse consequence that may ensue." | ( Chefer, VI; Shippenberg, TS; Zapata, A, 2007) |
| "Drug addiction is a process beginning with the initial exposure to a drug of abuse, and leading, in some individuals, to chronic habitual use, and high rates of relapse." | ( Kalivas, PW; Torregrossa, MM, 2008) |
| "Drug addiction is a devastating disease that affects millions of individuals worldwide." | ( McClung, CA, 2007) |
| "Today, drug abuse is highly linked to the spread of HIV/AIDS and to drug-related crimes in China." | ( Fang, Y; Lu, L; Wang, X, 2008) |
| "Outpatient substance abuse care also was more likely for patients in clinics with on-site case management and affiliated substance abuse care (OR=4." | ( Cleary, PD; Landon, BE; LeMaster, J; Ohl, ME, 2008) |
| "Development of substance dependence is influenced by multiple factors, e." | ( Ujike, H, 2008) |
| "Drug addiction is now considered a brain disease, because the abuse of drugs affects several brain functions." | ( Cunha-Oliveira, T; Oliveira, CR; Rego, AC, 2008) |
| "Addiction or substance dependence is a psychiatric disorder that affects many individuals in the general population." | ( Ackermans, L; Noblesse, LH; Stelten, BM; Temel, Y; Visser-Vandewalle, V, 2008) |
| "Drug abuse is still a serious problem of nowadays." | ( Charousová, P; Slamberová, R, 2008) |
| "Drug abuse is on the rise." | ( Aggarwal, N; Dhingra, VK; Lall, D; Vashist, RP, 2008) |
| "Substance use is common among individuals admitted to the critical care setting and may complicate treatment of underlying disorders." | ( O'Connor, PG; Tetrault, JM, 2008) |
| "Drug dependence is defined as a chronically relapsing disorder that is characterized by compulsive drug taking, inability to limit intake, and intense drug cravings." | ( Yamada, K, 2008) |
| "Drug addiction is a compulsive behavioral abnormality." | ( Diana, M; Lintas, A; Spiga, S, 2008) |
| "Drug addiction is a chronic, relapsing disorder that is characterized by a compulsion to take drug regardless of the adverse consequences that may ensue." | ( Chefer, VI; LeFevour, A; Shippenberg, TS, 2008) |
| "Drug dependence is a chronic, relapsing disorder in which compulsive drug-seeking and drug-taking behaviours persist despite serious negative consequences." | ( Gallo, A; Gorwood, P; Le Foll, B; Le Strat, Y; Lu, L, 2009) |
| "Substance abuse is a major health and social problem among Hong Kong youth and ketamine is the drug most commonly abused." | ( Cheung, YS; Lai, PB; Lee, KF; Ng, WW; Wong, J; Wong, SW, 2009) |
| "Drug abuse is a worldwide health concern in which addiction involves activation of the dopaminergic signaling pathway in the brain." | ( Bergey, EJ; Bonoiu, AC; Ding, H; Hu, R; Kumar, R; Mahajan, SD; Prasad, PN; Roy, I; Schwartz, SA; Yong, KT, 2009) |
| "Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs and the development of dependence and manifestation of a negative emotional state when the drug is removed." | ( Koob, GF, 2009) |
| "Drug addiction is conceptualized as chronic, relapsing compulsive use of drugs with significant dysregulation of brain hedonic systems." | ( Koob, GF, 2009) |
| "Because drug addiction is commonly thought to involve changes in brain circuits important for natural reinforcement, we first present the role of phasic dopamine release in appetitive and goal-directed behaviors in the context of contemporary theories regarding the function of dopamine." | ( Clark, JJ; Phillips, PE; Wanat, MJ; Willuhn, I, 2009) |
| "Drug abuse is often initiated as a maladaptive mechanism for coping with stress." | ( Lucki, I; Valentino, RJ; Van Bockstaele, E, 2010) |
| "Substance use is common among adolescents with treatment-resistant MDD." | ( Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Goldstein, BI; Mayes, T; Onorato, M; Ryan, N; Shamseddeen, W; Spirito, A; Vitiello, B; Wagner, KD; Zelazny, J, 2009) |
| "Drug addiction is one of the top three health concerns in the United States in terms of economic and health care costs." | ( Blendy, JA; Briand, LA, 2010) |
| "Drug dependence is a chronic brain disease characterized by recurrent episodes of relapse, even when the person is motivated to quit." | ( Booij, J; Crunelle, CL; Miller, ML; van den Brink, W, 2010) |
| "Drug addiction is believed to be a chronic and convertible disease resulting in the obtrusive aim of drugs ingestion and the use of them in spite of health risk and life threat." | ( Białecka, M; Borowiak, K; Machoy-Mokrzyńska, A, 2007) |
| "Drug addiction is a chronic brain disorder leading to complex adaptive changes within the brain reward circuits." | ( Maldonado, R, 2010) |
| "Substance use is associated with poor mental health, but little is known regarding how use of multiple substances is associated with mental health, particularly longitudinally, in community studies." | ( Booth, BM; Carlson, RG; Curran, G; Falck, R; Frith, S; Han, X; Leukefeld, C; Wright, P, 2010) |
| "Drug addiction is one such disorder; it is both chronic and relapsing, and one prominent risk factor for a relapse episode is the presentation of environmental cues that have previously been associated with drugs of abuse." | ( Everitt, BJ; Milton, AL, 2010) |
| "Substance abuse is associated with changes in dopaminergic neurotransmission of dopamine D1 and D2 receptors." | ( de Haan, L; Machielsen, MW, 2009) |
| "Substance use is also associated with a range of harmful effects to the individual and society as a whole." | ( Hesse, M, 2010) |
| "Drug addiction is marked by long-lasting changes in behavior that result, in part, from altered patterns of gene expression within limbic forebrain regions, such as the nucleus accumbens (NAc)." | ( Maze, I; Russo, SJ, 2010) |
| "Vulnerability to drug abuse is related to both reward seeking and impulsivity, two constructs thought to have a biological basis in the prefrontal cortex (PFC)." | ( Bardo, MT; Darna, M; Dwoskin, LP; Huettl, P; Jiang, Y; Joseph, JE; Kelly, TH; Perry, JL; Zimmerman, RS, 2011) |
| "Prescription drug abuse is a significant and growing health and socio-economical problem in the US and the world." | ( Hamed, E; Moe, D, 2010) |
| "substance abuse is an important cause of ischemic stroke in the young." | ( Leupold, D; Wartenberg, KE, 2011) |
| "Multiple substance use is a common problem among heroin users." | ( Chongsuvivatwong, V; Li, J; Li, L; McNeil, E; Sangthong, R, 2011) |
| "Drug addiction is not the same as drug dependency because dependency may not manifest as an addictive behavior." | ( Detar, DT, 2011) |
| "Chronic pain and substance abuse are common problems." | ( Clark, MR; Treisman, GJ, 2011) |
| "Drug addiction is a chronic neuronal disease." | ( Li, MD; Wang, J; Yuan, W, 2011) |
| "Drug addiction is characterized by compulsive drug-seeking and drug-taking behaviors (craving), and loss of control over intake despite impairment in health, social, and occupational functions." | ( Cador, M; Caille, S; Clemens, K; Stinus, L, 2012) |
| "Prescription drug abuse is the fastest growing drug problem in the United States." | ( , 2012) |
| "A hallmark of drug addiction is the uncontrollable desire to consume drugs at the expense of severe negative consequences." | ( Smit, AB; Spijker, S; Van den Oever, MC, 2012) |
| "Prescription drug abuse is a major concern in several countries." | ( Frauger, E; Lapeyre-Mestre, M; Micallef, J; Nordmann, S; Pauly, V; Pourcel, L; Pradel, V; Thirion, X, 2012) |
| "Drug abuse is a social, moral, and penal problem in Poland since many years." | ( Sienkiewicz, P, 2011) |
| "Drug addictions are complex disorders that require multiple approaches, including the use of pharmacotherapies." | ( Montoya, ID, 2012) |
| "Drug addiction is an important social problem in many countries." | ( Nagaya, D; Navaratnam, V; Ramanathan, S; Ravichandran, M, 2012) |
| "Substance use disorders are a large public health problem in the United States." | ( Ballantyne, J; Krashin, D; Murinova, N, 2012) |
| "Substance abuse is a frequent comorbidity of both disorders and is associated with serious health issues." | ( Gyertyán, I; Kiss, B; Román, V; Sághy, K; Szombathelyi, Z, 2013) |
| "Drug abuse is often seen as a unitary phenomenon, partly as a result of the discovery over the past three decades of shared mechanisms of action for addictive substances." | ( Badiani, A; De Luca, MT; Meringolo, M; Spagnolo, PA, 2012) |
| "Because drug addiction is increasingly seen as the inappropriate learning of strongly reinforcing stimuli, the role of the cytoskeleton in shaping drug memories has been of increasing interest in recent years." | ( Cowan, CW; Rothenfluh, A, 2013) |
| "Substance addiction is damaging to the health of persons, families, and society." | ( Piacentine, LB, 2013) |
| "Drug dependence is still to be recognized in developing countries as a significant public health problem and literature on the magnitude of this problem is limited." | ( Holla, R; Kanchan, T; Kulkarni, V; Kumar, N; Mithra, P; Papanna, MK; Sarathy, S; Thapar, R; Unnikrishnan, B, 2013) |
| "Substance abuse is a significant public health concern both domestically and worldwide." | ( Collier, AD; Echevarria, DJ, 2013) |
| "Polysubstance use is prevalent in individuals using buprenorphine or methadone nonmedically, with benzodiazepines being a common co-ingestant." | ( Doyon, S; Klein-Schwartz, W; Lee, SC; Welsh, C, 2014) |
| "Drug abuse is a serious problem associated with different pathological outcomes including modulating the immune system." | ( Alvi, A; Bin Ali Jerah, A; Rizwan, M; Sunosi, RA, 2014) |
| "If substance use is initiated, these at-risk youth can also develop heightened responses to drug-paired cues." | ( Leyton, M; Vezina, P, 2014) |
| "Substance use disorders are prevalent and debilitating." | ( Chamberlain, SR; Grant, JE, 2014) |
| "Addiction and substance abuse are found ubiquitously throughout human society." | ( Caramillo, EM; Collier, AD; Echevarria, DJ; Khan, KM; Mohn, RS, 2014) |
| "An epidemic of prescription drug abuse is disproportionately impacting the mentally ill." | ( Brown, AM; Chambers, RA; Fernandes, TJ; Greene, MS; Hackman, DT; Wright, ER, 2014) |
| "Substance use disorders are common in primary care settings, but detection, assessment, and management are seldom undertaken." | ( Duncan, MH; Merrill, JO, 2014) |
| "Drug addiction is a serious relapsing disease that has high costs to society and to the individual addicts." | ( Dasari, T; Nielsen, DA; Nielsen, EM; Spellicy, CJ, 2014) |
| "Substance dependence is a chronic relapsing disorder, which appears to involve neuroadaptive changes in cellular signaling and downstream gene expression." | ( Feng, WY; Liang, JH; Wen, RT; Zhang, HT, 2015) |
| "Drug addiction is a serious health problem." | ( Eriksson, K; Råholm, MB; Thorkildsen, KM, 2015) |
| "Substance use disorders are a leading cause of morbidity and mortality in the United States." | ( Friedmann, PD; Park, TW, 2014) |
| "Although substance abuse is considered a way of life in them, such patients rarely seek treatment because of the stigma and fear of discrimination." | ( Deb, KS; Elawadhi, D; Goyal, S; Kaw, N, 2014) |
| "Substance use is still a major issue among adolescents around the world, underscoring the need for continued research and interventions." | ( Blum, RW; Brahmbhatt, H; Levy, PA; Lian, Q; Mashimbye, L; Ojengbede, O; Olumide, AO; Robinson, AC; Sonenstein, FL, 2014) |
| "Drug abuse is a major comorbidity of HIV infection and cognitive disorders are often more severe in the drug abusing HIV infected population." | ( Berman, JW; Calderon, TM; Coley, JS; Eugenin, EA; Gaskill, PJ, 2015) |
| "Drug dependence is a serious health and social problem." | ( El Rawas, R; Saria, A, 2016) |
| "Drug addiction is one of the most serious social problems in the world today and addicts are always at a high risk of acquiring HIV infection." | ( Bi, R; Guo, H; Hu, QX; Liu, FL; Logan, I; Yang, BQ; Yao, YG; Zhang, AM; Zhang, W; Zheng, YT, 2016) |
| "Drug addiction is a serious disease with damaging effects on the brain and physical health." | ( Bauer, IE; Graham, DP; Nielsen, DA; Soares, JC, 2015) |
| "Substance use is prevalent in persons with HIV-HCV co-infection and may interfere with ART." | ( Cherry, C; Eaton, L; Grebler, T; Kalichman, MO; Kalichman, SC; Kegler, C; Washington, C, 2015) |
| "Drug addiction is characterized by widespread abnormalities in brain function and neurochemistry, including drug-associated effects on concentrations of the excitatory and inhibitory neurotransmitters glutamate and gamma-aminobutyric acid (GABA), respectively." | ( London, ED; Moeller, SJ; Northoff, G, 2016) |
| "Drug addiction is a complex, relapsing disorder in which compulsive drug-seeking behavior can persist despite aversive consequences." | ( Alaghband, Y; Bredy, TW; Wood, MA, 2016) |
| "Drug addiction is a chronic relapsing disorder that comes at a high cost to individuals and society." | ( Uys, JD; Womersley, JS, 2016) |
| "While polysubstance use is a widespread phenomenon among cocaine users, its role in WM alterations in cocaine users is currently unknown." | ( Caan, MWA; Homberg, JR; Kaag, AM; Reneman, L; van den Brink, W; van Wingen, GA, 2017) |
| "Polysubstance use is associated with alterations in different components of executive functioning such as working memory and response inhibition." | ( Caracuel, A; Valls-Serrano, C; Verdejo-García, A, 2016) |
| "Drug abuse is negatively associated with planning abilities, and intelligence is positively associated with planning performance in real-world tasks." | ( Caracuel, A; Valls-Serrano, C; Verdejo-García, A, 2016) |
| "Substance use disorders are common among persons with HIV/AIDS." | ( Cohn, A; Ehlke, S; Elmasry, H; Niaura, R; Stanton, C, 2016) |
| "Substance abuse is found worldwide including among students." | ( Arora, A; Choudhary, S; Gowri, S; Kannan, S; Khosla, PP; Sudarasanan, S, 2016) |
| "Depression and substance use disorders are often comorbid, but the reasons for this are unclear." | ( Browne, CJ; Ng, E; Samsom, JN; Wong, AHC, 2017) |
| "Drug addiction is defined as a "pathological pattern of use of a substance", characterized by the loss of control on drug-taking-related behaviors, the pursuance of those behaviors even in the presence of negative consequences, and a strong motivated activity to assume substances." | ( Gasbarri, A; Nishijo, H; Patrono, E; Tomaz, C, 2016) |
| "Substance use is a major driver of the HIV epidemic and is associated with poor HIV care outcomes." | ( Armstrong, WS; Castellón, PC; Colfax, GN; Daar, ES; Das, M; del Rio, C; Douaihy, A; Drainoni, ML; Feaster, DJ; Ferris, DC; Gooden, L; Haynes, LF; Herrera, P; Jacobson, JM; Jain, MK; Lindblad, R; Lucas, GM; Mandler, RN; Matheson, T; McMahon, DK; Metsch, LR; Metzger, DS; Mugavero, MJ; Nijhawan, AE; Oden, N; Rodriguez, AE; Sorensen, JL; Stitzer, M; Sullivan, M; Tross, S; VanVeldhuisen, P; Vergara-Rodriguez, P, 2016) |
| "Depression and substance use are significant obstacles to effective HIV care." | ( Bangsberg, DR; Dilley, JW; Grelotti, DJ; Hammer, GP; Karasic, DH; Sorensen, JL; Tsai, AC, 2017) |
| "Substance use disorders are diagnosed as a manifestation of inappropriate behavioral allocation toward abused drugs and away from other behaviors maintained by more adaptive nondrug reinforcers (e." | ( Banks, ML, 2017) |
| "Drug addiction is a debilitating disorder and its pivotal problem is the high relapse rate." | ( Bosker, WM; Neuner, I; Shah, NJ, 2017) |
| "In states where substance use is considered child abuse this may be especially catastrophic." | ( Mark, K; Terplan, M, 2017) |
| "Substance use is highly prevalent among men who have sex with men (MSM) and is associated with individual-level sexual risk behaviors." | ( Brown, RE; Hern, J; Santos, GM; Turner, C, 2017) |
| "Comorbid substance abuse is known to blunt response to treatment for underlying psychiatric disorders, but it has not been investigated in schizophrenia when comparing the effects of long-acting injectable antipsychotics with those of oral antipsychotics." | ( Alphs, L; Bermak, J; Lynn Starr, H; Mao, L; Rodriguez, S, 2018) |
| "Polysubstance use is highly prevalent among US reproductive-aged women reporting nonmedical opioid use." | ( Barry, CL; Gollust, S; Graves, AJ; Jarlenski, M; Kennedy-Hendricks, A; Kozhimannil, K, 2017) |
| "Substance use disorders are major contributors to excess mortality among individuals with attention deficit hyperactivity disorder (ADHD), yet associations between pharmacological ADHD treatment and substance-related problems remain unclear." | ( Chang, Z; D'Onofrio, BM; Gibbons, RD; Hur, K; Lahey, BB; Larsson, H; Lichtenstein, P; Quinn, PD; Rickert, ME; Sjölander, A, 2017) |
| "Polydrug abuse is a known problem among opioid-dependent patients receiving opioid maintenance treatment (OMT)." | ( Heikman, PK; Muhonen, LH; Ojanperä, IA, 2017) |
| "Drug addiction is a severe psychiatric disorder characterized by the compulsive pursuit of drugs of abuse despite potential adverse consequences." | ( Kim, HJ; Kim, JH; Lee, JH; Yun, K, 2017) |
| "Substance dependence is a chronic relapsing brain disorder associated with adaptational changes in synaptic plasticity and neuronal functions." | ( Liang, JH; Wen, RT; Zhang, HT, 2017) |
| "Substance use is associated with impaired social cognition." | ( Fluharty, ME; Heron, J; Munafò, MR, 2018) |
| "Drug addiction is classified as a chronic relapse nature brain disease with complicated neurobiology mechanisms." | ( Duan, S; Guo, R; Huang, J; Lin, Z; Lv, J; Ma, S; Ma, Y; Sun, Z; Xie, L, 2017) |
| "Substance abuse is serious public health problem for which there are few effective pharmacotherapies." | ( Collins, GT; France, CP; Gerak, LR, 2018) |
| "Drug addiction is a chronic brain disorder characterized by the compulsive use of drugs." | ( Chen, M; Cui, D; Lai, B; Luan, W; Ma, L; Ma, Q; Song, J; Yang, H; Zhang, J; Zhao, Y; Zheng, P, 2017) |
| "Substance use disorders are chronically relapsing conditions and relapse risk persists for multiple reasons including craving induced by drug contexts, susceptibility to stress, elevated anxiety, and impaired impulse control." | ( Banks, SL; Gonzalez-Cuevas, G; Hammell, DC; Kerr, TM; Martin-Fardon, R; Parsons, LH; Stinchcomb, AL; Stouffer, DG; Weiss, F, 2018) |
| "Drug abuse is an increasing problem among young adults in European countries." | ( Dhein, S; Guenther, J; Salameh, A; Schmelmer, K, 2018) |
| "Drug addiction is a worldwide societal problem and public health burden, and results from recreational drug use that develops into a complex brain disorder." | ( Darcq, E; Kieffer, BL, 2018) |
| "Drug addiction is an aberrant memory that shares the same memory processes as other memories." | ( Li, JX; Liu, JF; Tian, J, 2019) |
| "Alcohol and substance use disorders are important predictors for suicidal behavior." | ( Brent, D; Chang, HB; Douaihy, A; Gray, K; Marsland, A; Melhem, NM; Munroe, S; Porta, G, 2019) |
| "Thus, substance use is not only related to increased habit formation but also to difficulty disengaging from learned habits." | ( Byrne, KA; Otto, AR; Pang, B; Patrick, CJ; Worthy, DA, 2019) |
| "Polysubstance use is associated with relapse and poor treatment outcomes among people dependent on heroin." | ( Anderson, BJ; Bailey, GL; Kenney, SR; Stein, MD, 2019) |
| "Drug addiction is a major public health concern across the world for which there are limited treatment options." | ( Calipari, ES; Kutlu, MG; Sanders, C; Thibeault, KC, 2019) |
| "Though substance use is a known risk factor for self-discharge, patients self-discharging during treatment for acute poisoning have not previously been described." | ( Brekke, M; Ekeberg, Ø; Jacobsen, D; Vallersnes, OM, 2019) |
| "Substance use disorders are a widely recognized problem, which affects various levels of communities and influenced the world socioeconomically." | ( Coskunol, H; Moulahoum, H; Timur, S; Zihnioglu, F, 2019) |
| "Substance addiction is a chronic, relapsing mental disorder Characterized by compulsive drug seeking, and loss of control over drug intake and relapse after prolonged abstinence." | ( Awan, S; Batool, S; Ghafoor, S; Habib, R; Javed, T; Ntepe, LJM; Nurulain, SM; Rumman, B, 2019) |
| "Its use as a substance abuse is not properly described in literature." | ( Agarwal, M; Bhushan, D, 2019) |
| "Substance use disorders are a major public health concern in Punjab." | ( Banavaram, AA; Chavan, BS; Das, S; Garg, R; Puri, S, 2019) |
| "Drug addiction is a chronic relapsing disorder of compulsive drug use." | ( Carroll, A; Elmer, GI; Hope, BT; Koya, E; L De Ness, G; Laque, A; M Kerr, T; Nedelescu, H; Suto, N; Wagner, GE; Watry, D; Weiss, F, 2019) |
| "Adolescent substance use is an ever-changing topic that can be difficult to stay on top of its many components." | ( Khan, L, 2019) |
| "Parent substance use is a risk factor early adolescents' substance use." | ( Capaldi, DM; Kerr, DCR; Owen, LD; Tiberio, SS, 2020) |
| "Substance use is prevalent in Canada, yet treatment is inaccessible." | ( Hulme, J; Sheikh, H; Wiercigroch, D, 2020) |
| "Substance use disorders are difficult to recognize in older adults due to medical comorbidity, neurocognitive impairment, and functional decline." | ( Burton, MC; Pagali, S; Seim, L; Vijapura, P, 2020) |
| "Historically, substance use disorders are more prevalent in men than women, though this gap is closing." | ( Barker, JM; Giacometti, LL, 2020) |
| "Drug addiction is a multifactorial disorder resulting from the complex interaction between biological, environmental and drug-induced effects." | ( Amaral, IM; El Rawas, R; Hofer, A, 2020) |
| "Sex differences in drug addiction are well established both for humans and animal models." | ( Harp, SJ; Lynch, WJ; Martini, M; Rissman, EF, 2020) |
| "Drug addiction is not a static condition but rather a chronically relapsing disorder." | ( Jang, WJ; Jeong, CH; Kim, J; Kim, S; Lee, S; Lee, SK; Yu, H, 2020) |
| "Substance use is common among youth experiencing homelessness (YEH)." | ( Christie, NC; Davis, JP; DiGuiseppi, GT; Rice, E, 2020) |
| "Maternal illicit drug abuse is associated with future child fractures due to assault and transport accidents." | ( Auger, N; Ayoub, A; Lee, GE; Low, N; Luu, TM, 2021) |
| "Premorbid substance use is widely recognized as a crucial factor in early psychosis." | ( Compton, MT; Kelley, ME; Langlois, S; Zern, A, 2021) |
| "Polysubstance use is defined as the use of more than one non-prescribed licit or illicit substance either concurrently or simultaneously." | ( Ab Majid, NL; Abd Hamid, HA; Ahmad, A; Lsmail, H; Mat Rifin, H; Miaw Yn, JL; Mohd Yusoff, MF; Rashid, RA; Robert Lourdes, TG; Rodzlan Hasani, WS; Saminathan, TA, 2021) |
| "Drug dependence is a debilitating disorder, affecting 30 million people worldwide." | ( Herrera-Solis, A; Mendez-Díaz, M; Morelos, J; Prospero-Garcia, OE; Ruiz-Contreras, AE, 2021) |
| "Drug addiction is one of the leading causes of mortality worldwide." | ( Cai, J; Che, X; Liu, Y; Wu, C; Xu, T; Yang, J, 2021) |
| "Substance use is subject to multiple risk factors and varies by substance class, sport discipline, country and gender, among other factors." | ( Berg, X; Bitar, R; Claussen, MC; Exner, J; Herdener, M; Pichler, EM; Seifritz, E, 2021) |
| "Drug addiction is a major worldwide medical and social problem." | ( Chen, L; Ru, Q; Wu, YX; Zhou, M, 2021) |
| "Drug addiction is a chronically relapsing disorder, affecting people from all walks of life." | ( Kim, HY; Lee, BH; Lee, MY; Yang, CH, 2021) |
| "Substance use disorders are complex biopsychosocial disorders that have substantial negative neurocognitive impact in various patient populations." | ( Cadet, JL; Jayanthi, S, 2021) |
| "Substance abuse is a significant public health concern that disproportionately burdens males and low-income communities." | ( Brousseau-Paradis, C; Castellanos-Ryan, N; Chadi, N; Côté, SM; Nagin, D; Orri, M; Séguin, JR; Tremblay, RE; Vergunst, F; Vitaro, F, 2022) |
| "Drug addiction is a chronic relapsing disorder, as more than 80% of former drug users relapse within a year after quit attempts have ended." | ( Carroll, ME, 2021) |
| "Drug addiction is underscored by the transition from experimental use to dependent use of addictive drugs." | ( Gao, B; Li, T; Liang, M; Liu, X; Qian, H; Shang, Q; Wang, J; Xi, Z; Xiao, J, 2021) |
| "Substance use is problematic in young women, particularly in pregnancy." | ( Auger, N; Ayoub, A; Lo, E; Low, N; Luu, TM, 2021) |
| "Substance use is increasingly prevalent among women." | ( Hudson, S; Kelly, PJ; Robinson, LD; Rodriguez, AS, 2022) |
| "Substance use disorders are considered chronic but treatable." | ( Worley, J, 2021) |
| "Self-reported substance use is more likely to be influenced by underreporting bias compared to the biological markers." | ( Baradaran, HR; Hojati, Z; Janani, L; Khalagi, K; Khalili, P; Motevalian, SA; Nadimi, AE; Rahimi-Movaghar, A; Rahmani, A; Rajabi, Z, 2021) |
| "The prevalence of substance use is also high among those who were working (35%)." | ( Dhillon, P; Kumar, P; Paul, R; Srivastava, S, 2021) |
| "Substance use is a major public health concern worldwide." | ( Kosten, TR; Truong, TT, 2022) |
| "Chronic pain and substance use disorders are serious conditions that are prevalent among homeless populations." | ( Cabanis, M; Choi, F; Hwang, SW; Krausz, M; Nikoo, M; Nikoo, N; Schütz, CG; Somers, J; Vogel, M; Westenberg, JN, 2021) |
| "Drug use disorders are associated with increased risk of self-harm." | ( Chai, Y; Chan, EW; Chan, SKW; Luo, H; Man, KKC; Wei, Y; Wong, ICK; Yip, PSF, 2022) |
| "Drug addiction is associated with disruption of a multitude of biomarkers in various brain regions, particularly in the reward centre." | ( Abdullah, M; Huang, LC; Lin, SH; Yang, YK, 2022) |
| "Drug addiction is characterized by impaired response inhibition and salience attribution (iRISA), where the salience of drug cues is postulated to overpower that of other reinforcers with a concomitant decrease in self-control." | ( Alia-Klein, N; Ceceli, AO; Goldstein, RZ; King, S; Malaker, P; Parvaz, MA; Schafer, M; Sharma, A, 2023) |
| "Drug addiction is a chronic brain disease characterized by compulsive drug-seeking and drug-taking behaviors despite the major negative consequences." | ( Li, JX; Liu, J; Wu, R, 2022) |
| "Drug addiction is a chronic relapsing disorder that makes it a global problem." | ( Akbarabadi, A; Ashabi, G; Mokri, A; Sadat-Shirazi, MS; Sadeghi-Adl, M; Zarrindast, MR, 2023) |
| "Drug addiction is a chronic and relapsing brain disorder characterized by compulsive drug seeking and continued drug use despite adverse consequences." | ( Cen, X; Han, S; Li, S; Qin, F; Tian, J; Wang, H; Zhao, Y, 2022) |
| "Drug abuse is one of the many risky behaviors that can be seen during adolescence." | ( Akgül, S; Alan, BE; Kızılkan, MP, 2022) |
| "Substance use disorders are among the commonest mental disorders in childhood and adolescence." | ( Arnaud, N; Paschke, K; Thomasius, R, 2022) |
| "While polysubstance use is highly prevalent among people who use drugs, the field lacks a reliable assessment that can detect detailed temporal patterns of polysubstance use." | ( Cottler, LB; Fitzgerald, ND; Knackstedt, L; Liu, Y; Setlow, B; Striley, CW; Wang, A, 2022) |
| "Substance use disorders are a leading cause of morbidity and mortality, and available pharmacological treatments are of modest efficacy." | ( Di Ciano, P; Hendershot, CS; Le Foll, B, 2022) |
| "Substance use disorders are associated with significant physical health comorbidities, necessitating an integrated treatment response." | ( Deane, FP; Ivers, R; Kelly, PJ; Larance, B; Osborne, B; Robinson, LD, 2022) |
| "Youth drug addiction is a significant social and health problem." | ( Gajewska-Ormińska, K; Krakowczyk, H; Machura, E; Szczepańska, M; Wróblowska-Grzonka, U; Ziora, K, 2022) |
| "Alcohol and/or substance use disorders are known to be a significant phenomenon in the Western world." | ( Balbinot, P; Pellicano, R; Testino, G, 2022) |
| "Drug addiction is associated with blunted neural responses to nondrug rewards, such as money, but heightened responses to drug cues that predict drug-reward outcomes." | ( Ersche, KD; Nestor, LJ, 2023) |
| "Substance use is often initiated during adolescence and young adulthood, and interventions during these crucial years have the potential to impact the lifetime risk of stimulant use disorder and associated harms." | ( Hadland, SE; LaBossier, NJ, 2022) |
| "The research on substance use disorders is ongoing in the quest to find anti-addiction vaccines to treat drug abuse." | ( Bury, E; Cameriere, R; Cingolani, M; Ribeiro, ILA; Scendoni, R, 2022) |
| "Substance abuse is a worldwide problem with serious repercussions for patients and the communities where they live." | ( Al-Trad, B; Amawi, H; Hall, FS; Hammad, AM; Naser, A; Tiwari, AK, 2023) |
| "Substance abuse is a worldwide problem with serious repercussions for patients and the communities where they live." | ( Al-Trad, B; Amawi, H; Hall, FS; Hammad, AM; Naser, A; Tiwari, AK, 2023) |
| "Substance use is associated with reduced adherence to other medications, but associations between substance use and adherence to PrEP are less clear." | ( Canidate, SS; Cook, RL; Gebru, NM; Leeman, RF; Liu, Y; Pavila, E; Schaefer, SE, 2023) |
| "Substance use is associated with higher rates of postoperative complications, overall costs, and revision surgery following arthroscopic RCR." | ( Althoff, A; Arney, M; Brunette, C; Kamalapathy, P; Raso, J; Werner, BC, 2023) |
| "Substance use is a major public health problem in adolescents and young adults (AYA) and is particularly dangerous for AYA with type 1 diabetes (T1D) due to additional health consequences related to T1D." | ( Gurnurkar, S; Sannegowda, R; Suk, R; Villalba, K; Wasserman, RM, 2023) |
| "Polysubstance use is the use of more than one non-prescribed licit or illicit substance at one time." | ( Ab Majid, NL; Abd Hamid, HA; Ganapathy, SS; Mohd Yusoff, MF; Robert Lourdes, TG; Rodzlan Hasani, WS, 2023) |
| "GBMSM's substance use is usually explored in the context of its contribution to sexual risk." | ( Bourne, A; Dietze, P; Doyle, JS; Hellard, M; O'Keefe, D; Pedrana, A; Schroeder, SE; Wilkinson, AL, 2023) |
| "Polysubstance use is common among people with HIV infection (PWH) and with substance use disorder (SUD), but its effects are understudied." | ( Bertholet, N; Heeren, T; Saitz, R; Walley, AY; Winter, MR, 2023) |
| "Drug abuse is a serious problem in the United States, with over 90,000 drug overdose deaths nationally in 2020." | ( Altman, RB; Carpenter, KA, 2023) |
| "Adolescent substance use is a global concern." | ( Abiodun, OA; Makanjuola, AB; Omotoso, ABO, 2023) |
| "Polysubstance use is common among individuals seeking treatment for substance use disorders (SUD)." | ( Dunn, KE; Ellis, JD; Huhn, AS; Rabinowitz, JA; Ware, OD; Wells, J, 2023) |
| "Current polysubstance use is associated with significant clinical complexity." | ( Dunn, KE; Ellis, JD; Huhn, AS; Rabinowitz, JA; Ware, OD; Wells, J, 2023) |
| "Psychoactive substance use is associated with sleep characteristics and clinically relevant correlates in people with untreated OSA." | ( Baldassarri, SR; Blohowiak, RF; Byrne, S; Chu, JH; Deng, A; Kushida, C; Xu, Z; Yaggi, HK; Zinchuk, A, 2023) |
| "Polysubstance use is prevalent but there is a paucity of research exploring effective treatments and interventions." | ( Chan, GCK; Connor, JP; Leung, J; Stjepanović, D, 2023) |
| "Adolescent substance use is a significant public health problem and there is a need for effective substance use preventions." | ( Chaplin, TM; Curby, TW; Gonçalves, SF; Kisner, MA; Niehaus, CE; Thompson, JC, 2023) |
| "Drug addiction is a disease state where the body relies on a substance for normal functioning and develops a physical dependence leading to compulsive and repetitive use despite negative consequences to the user's health, mental state, or social life." | ( Stephenson, RJ; Toth, I, 2023) |
| "Rates of substance use are also higher among young adults compared with other age groups." | ( Agius, E; Brown, S; Ellis, JD; Hicks, DL; Kcomt, L; Lee, G; Resko, SM; Sabol, BM, 2023) |
| "People with substance use disorders are highly prevalent in the carceral system." | ( Arndt, S; Bormann, NL; Lynch, AC; Miskle, B; Weber, AN, 2023) |
| "While substance use is known to influence cardiovascular health, most prior studies only consider one substance at a time." | ( Coffin, PO; Hsue, P; Kazi, DS; Lynch, KL; Ravi, A; Riley, ED; Suen, LW; Vittinghoff, E; Win, S; Wu, AHB, 2023) |
| "Substance use is a problem that affects people all over the world and is prevalent in different age groups." | ( Ali, IA; Mohamed, HSM, 2023) |
| Excerpt | Reference |
|---|
| "Early detection and treatment of drug abuse should minimize some of the difficulties involved in management of treatment-resistive patients with chronic pain." | ( Finlayson, RE; Maruta, T; Swanson, DW, 1979) |
| "Patients from a polydrug abuse treatment program were titrated with either secobarbital or methaqualone, their primary drug of abuse, to a state of mild intoxication, consisting of lateral and vertical nystagmus, ataxia, slurred speech, and drownsiness." | ( Comstock, EG; Faulkner, TP; Hayden, JH; Mehta, CM; Olson, DA, 1979) |
| "Real life drug abusers ten to utilize drugs in a cyclic pattern of intermittently increasing doses and then "crashing off" depending on the availability of drugs and psychiatric treatment." | ( Flemenbaum, A, 1977) |
| "The second is on teenage drug abusers admitted to treatment." | ( Istiphan, I, 1977) |
| "The rats (drug dependence-experimented rats) who survived the first stage of this experiment were continuously subjected to re-administration by the same dosage schedule as in Exp." | ( Tagashira, E; Yanaura, S, 1975) |
| "On the hypothesis that drug addiction may be due to "masked depression", lithium was administered to 20 opiate addicts." | ( Altamura, AC, 1975) |
| "A diverse group of drug abusers in New Haven has benefited from a multifaceted treatment program at the Connecticut Mental Health Center's drug dependence unit." | ( , 1975) |
| "Counselors of HIV-afflicted substance abusers not only must apply counseling strategies directed toward curbing drug use, but also are called upon to assess suicide risk, attend to the promotion of social support, treat adverse affective reactions, and respond to spiritual and existential concerns." | ( Capone, CT; Condren, R; DeRovira, N; Katowsky, K; Melchionda, R; Peterson, M, 1992) |
| "Sixty substance abusers dually diagnosed with obsessive-compulsive disorder (OCD) and voluntarily admitted to a drug-free therapeutic community were randomly assigned to one of three treatment conditions." | ( Fals-Stewart, W; Schafer, J, 1992) |
| "Although patients with a history of substance abuse reported higher levels of anxiety and depression at presentation for treatment than patients without such histories, the two groups reported a similar age of onset of their bulimia nervosa and similar severity of eating pathology with regards to binge and vomit frequencies and measures of concern about body shape and weight." | ( Pike, KM; Strasser, TJ; Walsh, BT, 1992) |
| "The results suggest that for male substance abusers in the lower socioeconomic levels, the Cleveland criteria may not be effective in differentiating patients who can manage well with day hospital treatment and those who require inpatient treatment." | ( Alterman, AI; McKay, JR; McLellan, AT, 1992) |
| "Current and lifetime prevalence of substance use and psychiatric disorders was determined by administering the NIMH-DIS, revised to cover DSM-III-R diagnoses, to a sample of 1007 young adults." | ( Andreski, P; Breslau, N; Kilbey, MM, 1992) |
| "Two hundred Norwegian substance abusers who consecutively applied for treatment in a hierarchical therapeutic community were divided into two different groups according to intake procedures: the intake group (IG) and the nonintake group (No-IG)." | ( Ravndal, E; Vaglum, P, 1992) |
| "Female substance abusers' attributions about the stability and globality of positive and negative life events were used as predictors of successful completion of a halfway-house treatment program." | ( Gutierres, SE; Huselid, RF; Self, EA, 1991) |
| "Drug use by patients during inpatient substance abuse treatment is frequently a cause of premature hospital discharge." | ( Greenfield, SF; Griffin, ML; Weiss, RD, 1992) |
| "Rhode Island's Division of Substance Abuse asked us to assess the State's drug treatment needs and make recommendations regarding its treatment system for the next three years." | ( Ahmadifar, NW; Breer, P; McAuliffe, WE; Spino, C, 1991) |
| "The validity of the Drug Abuse Scale (T) from the Million Clinical Multiaxial Inventory (MCMI) was studied by administering the MCMI to 110 male veterans seeking treatment for opioid or cocaine dependence." | ( Calsyn, DA; Daisy, F; Saxon, AJ, 1991) |
| "As with other forms of drug abuse, patients may deny or hide their use of steroids while seeking treatment for bothersome side effects or other problems." | ( Beresford, TP; Blow, FC; Brower, KJ; Catlin, DH; Eliopulos, GA, 1991) |
| "Informing drug abusers in treatment regarding positive HIV-serostatus was not associated with a lower treatment-retention rate or adverse psychological reactions when counseling regarding HIV issues was integrated with drug abuse treatment." | ( Brown, BS; Haertzen, CA; Hess, JM; Weddington, WW, 1991) |
| "The diagnosis of other alcohol and drug dependence in cocaine dependence has important impact on etiology, prognosis, and treatment." | ( Gold, MS; Klahr, AL; Miller, NS, 1990) |
| "The recent escalation of drug abuse in the US has increased the need for treatment enormously." | ( Amble, FR, 1990) |
| "The implications for drug abuse treatment were determined." | ( Calsyn, DA; Erickson, L; Haver, VM; Saxon, AJ, 1990) |
| "The validity of the Drug Abuse Scale (T) from the Millon Clinical Multiaxial Inventory (MCMI) was studied by administering the MCMI to 75 White male veterans who were seeking treatment for opioid or cocaine dependence and 60 White male veterans without diagnoses of drug dependence who were receiving psychiatric care." | ( Calsyn, DA; Daisy, F; Saxon, AJ, 1990) |
| "The diagnoses of other substance use and dependence in cocaine dependence has important impact on etiology, prognosis and treatment." | ( Belkin, BM; Gold, MS; Miller, NS, 1990) |
| "The significance of beta-endorphin for drug dependence was explored by measuring the levels of beta-endorphin-immunoreactivity (beta E-IR) in plasma and parts of pituitary and brain of rats self-administering heroin or cocaine as compared to animals offered saline." | ( De Vry, J; Sweep, CG; Van Ree, JM; Wiegant, VM, 1989) |
| "The diagnoses of other alcohol and drug dependence in cocaine dependence and in family members of probands with cocaine dependence have important implications for etiology, prognosis, and treatment." | ( Belkin, BM; Gold, MS; Klahr, AL; Miller, NS, 1989) |
| "The literature on drug abuse treatment is reviewed in two sections." | ( Allison, M; Hubbard, RL, 1985) |
| "Centres for the treatment of drug abusers are often integrated with regional psychiatric hospitals and are the focus of the British response to opiate addiction." | ( Bucknall, AB; Robertson, JR; Strachan, JG, 1986) |
| "Thirty-two patients with coexisting substance abuse and other psychiatric disorders were treated in a unique outpatient pilot program that used techniques drawn from both psychiatric and substance abuse treatment." | ( Atkinson, RM; Kania, J; Kofoed, L; Walsh, T, 1986) |
| "Sixty-one substance abuse patients were treated for EMP." | ( Cunningham, JN; Hoover, EL; Hsu, HK; Minnard, E; Toporoff, B; Webb, H, 1988) |
| "In a sample of drug abusers in out-patient treatment in Zurich in 1987, seropositivity was documented for 42% of male and 63% of female patients." | ( Uchtenhagen, A, 1988) |
| "Because the current epidemic of drug abuse has touched all levels of society, the primary care physician is increasingly called on to identify, monitor, and treat persons with drug abuse problems." | ( Tennant, F, 1988) |
| "Neuropsychological assessment of substance abusers frequently proves useful for the evaluation of those aspects of cognitive functioning that may be relevant for optimal therapeutic management and treatment planning." | ( Miller, L, 1985) |
| "The goal of drug abuse treatment is to decrease the dominance of drug-related behaviors while enhancing the dominance of alternative socially acceptable behaviors." | ( Bigelow, GE; McCaul, ME; Stitzer, ML, 1985) |
| "Similarities between drug addiction and psychotic illness suggested that drug addicts could be treated with intensive ECT and phenothiazine drugs, a therapeutic approach effective in more serious psychotic illnesses." | ( Roper, P, 1966) |
| "There was no tendency to physical drug dependence during treatment and during a one-week placebo phase after discontinuation of Psyton." | ( Jellinger, K; Koeppen, D; Rössner, M, 1982) |
| "Different theories of drug abuse and treatment generate different predictions of perceived emotional effects of treatment." | ( Chaney, EF; Roszell, DK, 1983) |
| "Several compounds used clinically in drug abuse therapy were evaluated for genetic activity in a series of in vivo and in vitro assays." | ( Braude, M; Brockman, H; Brusick, D; Hung, C; Jagannath, D; Matheson, D, 1981) |
| "Several compounds used clinically in drug abuse therapy were evaluated for genetic activity in a series of in vivo and in vitro assays." | ( Braude, M; Brockman, H; Brusick, D; Hung, C; Jagannath, D; Matheson, D, 1981) |
| "While substance abuse is less prevalent in the elderly than in younger cohorts, it is common enough to constitute a significant public health problem, may increase in the future, is often overlooked by clinicians, and may be successfully managed if treatment is tailored to the special requirements of this age group." | ( Atkinson, RM; Kofoed, LL, 1982) |
| "Treatment and rehabilitation of the drug abuser in a jail setting is discussed." | ( Barton, WI, 1982) |
| "Temporal patterns of drug abuse treatment reentry and other outcome measures were examined over a three-year period based on a national follow-up sample of persons admitted to treatment in the Drug Abuse Reporting Program (DARP) during 1969 to 1972." | ( Savage, LJ; Simpson, DD, 1980) |
| "Treatment for drug addiction and longer Medicaid enrollment during pregnancy may offer important interventions to increase prenatal care of HIV-infected women." | ( Cocroft, J; Fanning, T; Hauck, W; Markson, L; Turner, BJ, 1995) |
| "Recognition of the heterogeneity among substance abusers has led to increased attention to the issue of client-treatment matching." | ( Dey, A; Monti, PM; Myers, MG; Rohsenow, DJ, 1995) |
| "The effectiveness of drug abuse treatment depends in part on meeting clients' medical and social needs related to drug abuse." | ( D'Aunno, T; Vaughn, TE, 1995) |
| "Attrition rates from substance abuse treatment are high." | ( Alterman, AI; Bedrick, J; Howden, D; Maany, I, 1994) |
| "Historically, directors of substance abuse treatment programs have been reluctant to adopt a smoke-free policy because of the fear of patient attrition." | ( Gottheil, E; Kurtz, JW; Menduke, H; Sterling, RC; Weinstein, SP, 1994) |
| "A sample of 161 substance abusers in treatment who had used any cocaine in the last 6 months completed questionnaires regarding the quantity, frequency, history, and perceptions of the consequences of their cocaine use." | ( Dey, AN; Monti, PM; Myers, MG; Rohsenow, DJ; Varney, SM; Zwick, WR, 1995) |
| "The men, all part of an inpatient drug abuse treatment research program, were randomly assigned after detoxification to receive placebo or either 6 or 12 mg daily buprenorphine treatment." | ( Garada, B; Holman, BL; Levin, JM; Mello, NK; Mendelson, JH; Schwartz, RB; Teoh, SK, 1995) |
| "Greater substance use at follow-up was predicted only by greater severity of alcohol and drug use at treatment admission, not by the number of services received during treatment." | ( Alterman, AI; Grissom, GR; Luborsky, L; McLellan, AT; Metzger, DS; O'Brien, CP; Woody, GE, 1994) |
| "Alexithymia is associated with substance abuse and may interfere with successful psychotherapy." | ( Downey, K; Lumley, MA; Pomerleau, OF; Stettner, L; Wehmer, F, 1994) |
| "A modest extent of previous or current substance abuse was observed among neuroleptic-resistant schizophrenic patients who subsequently received treatment with clozapine." | ( Buckley, P; Meltzer, HY; Thompson, P; Way, L, 1994) |
| "A total of 100 treatment-seeking substance users (50 men and 50 women) admitted to a university-based and a university-affiliated private chemical dependency hospital were compared with regard to demographic variables and comorbid psychiatric and personality diagnosis according to the Structured Clinical Interview for DSM-III-R after 14-21 days in treatment." | ( Brady, KT; Dustan, L; Grice, DE; Randall, C, 1993) |
| "Many patients with alcohol or drug abuse also have anxiety disorders for whom effective pharmacotherapy may be needed." | ( Ciraulo, DA; DuPont, RL; Griffiths, RR; Kosten, TR; Romach, MK; Sellers, EM; Woody, GE, 1993) |
| "As part of a National Institute on Drug Abuse grant-funded, double-blind, placebo-controlled trial to assess effectiveness of treating cocaine-abusing patients with fluoxetine, POMS data were collected at baseline and at 6 weeks (n = 90)." | ( Cowan, K; Elk, R; Grabowski, J; Rhoades, HM, 1993) |
| "We evaluated the medical histories, drug abuse patterns, sexual behaviors, serological studies for syphilis and hepatitis B infection and other laboratory studies in 1780 patients enrolled in New York City drug treatment clinics in 1987." | ( Ajuluchukwu, DC; Bailey, J; Brown, LS; Hickson, MJ, 1993) |
| "In the past, many substance abuse treatment programs used to emphasize the complete cessation of all medications including some potentially beneficial prescription medications." | ( Decker, KP; Ries, RK, 1993) |
| "The impact of length of stay in drug abuse treatment on follow-up drug use and criminal behavior has important clinical and policy implications." | ( French, MT; Hubbard, RL; Rachal, JV; Zarkin, GA, 1993) |
| "The intergenerational nature of substance abuse certainly argues for treatment not only for the mothers, but also for their children." | ( Farkas, KJ; Parran, TV, 1993) |
| "Despite the high rate of comorbidity, substance use disorders are generally not detected in acute care psychiatric settings, leading to incorrect diagnoses and ineffective treatments." | ( Alterman, AI; Drake, RE; Rosenberg, SR, 1993) |
| "Subjects were 281 intravenous drug abusers, 146 enrolled in outpatient methadone treatment (Treatment group) and 135 not in treatment (Community group)." | ( Bigelow, GE; Brooner, RK; Greenfield, L, 1995) |
| "There is a dearth of substance abuse treatment programs available to pregnant substance-using women." | ( Clark, KA; Martin, SL; Messer, K, 1996) |
| "A history of substance abuse is considered by many to be a contraindication to chronic opioid therapy for nonmalignant pain." | ( Dunbar, SA; Katz, NP, 1996) |
| "The National Institute on Drug Abuse's National Cooperative Agreement Project is a nationwide study of the injection and sexual behaviors of three populations of out-of-treatment drug users: injecting drug users (IDUs) who did not smoke crack cocaine, non-injecting crack smokers, and those engaging in both types of use." | ( Atkinson, JS; Montoya, ID, 1996) |
| "Axis I nonsubstance use disorder was associated with benzodiazepine use, while Axis II disorder was associated with both benzodiazepine and cocaine use early in treatment (P < 0." | ( Brooner, RK; Chutuape, MA; Kidorf, M; King, VL; Stitzer, ML, 1996) |
| "In the treatment of drug addiction, we apply pharmacological and psychological therapy but also psychosocial techniques to address the problems of an addict." | ( Täschner, KL, 1996) |
| "Forty-five percent of patients with substance abuse serious enough to prompt a presentation for treatment stated that the physician who cared for them was unaware of their substance abuse." | ( Mulvey, KP; Plough, A; Saitz, R; Samet, JH, 1997) |
| "The term drug dependence refers to psychic dependence (addiction), physical dependence, or both, in someone who administers a drug periodically or continuously." | ( Brust, JC, 1997) |
| "We report a 30 years-old intravenous drug abuser HIV-infected male with APL who attained complete clinical, morphological, and molecular remission after differentiation therapy with all-trans-retinoic acid (ATRA) followed by intensive chemotherapy." | ( Battle, M; Calvo, R; Feliu, E; Flores, A; Granada, I; Millá, F; Ribera, JM; Sancho, JM, 1997) |
| "The treatment of drug addiction by methadone is questioned: there is a shift from "all of abstinence" to "all for risk limitation"." | ( Remy, C, 1997) |
| "Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics." | ( Buckley, PF, 1998) |
| "The sites were two private substance abuse treatment facilities, one residential and rural, and one an urban partial hospital." | ( Abrams, DB; Martin, RA; Michalec, E; Monti, PM; Rohsenow, DJ, 1997) |
| "This study examined the functional and substance use status of methadone maintenance (MM) patients at treatment entry and 2 and 7 months later." | ( Alterman, AI; Cacciola, JS; McKay, JR; McLellan, AT; Rutherford, MJ, 1998) |
| "Urban substance abuse treatment center." | ( Ball, SA; Carroll, KM; McCance, E; Nich, C; Rounsavile, BJ, 1998) |
| "Treatment of alcohol and drug addictions, which has been neglected medically for a long time, is currently sparked with optimism." | ( Terenius, L, 1998) |
| "This study determines the extent of substance abuse in a treatment-resistant population and assesses the response of this population to olanzapine treatment." | ( Conley, RR; Gale, EA; Kelly, DL, 1998) |
| "Study participants applying for drug abuse treatment reported a higher level of perceived problem severity and a higher level of cognitive functioning than out-of-treatment drug users." | ( Bell, DC; Dayton, CA; Montoya, ID; Richard, AJ, 1998) |
| "Providing health services to drug abuse treatment clients improves their outcomes." | ( Alexander, JA; D'Aunno, TA; Friedmann, PD; Jin, L, 1999) |
| "In the national Drug Abuse Treatment Outcome Studies (DATOS), many clients in outpatient methadone treatment (OMT) and outpatient drug-free (ODF) modalities were admitted with multiple sex and needle-risk behaviors, but they reduced these risks significantly during treatment." | ( Broome, KM; Joe, GW; Simpson, DD, 1999) |
| "Both healthcare and substance abuse treatment providers should be cognizant that women may have greater exposure to these potent prescription medicines." | ( Simoni-Wastila, L, 2000) |
| "High prevalences of STDs among drug abusers indicate the need for integration of STD screening and treatment into drug treatment programs." | ( Bull, L; Holleman, M; Hwang, LY; Rickman, K; Ross, MW; Zack, C, 2000) |
| "Influence of parental alcohol/substance abuse on methadone maintenance therapy (MMT) outcome was examined in 164 DSM-III-R opioid dependent adults with no other current DSM Axis I disorder." | ( Gupman, AE; Johnson, EO; Miles, DR; Newlin, DB; Pickens, RW; Preston, KL; Soriano, J; Umbricht, A; van den Bree, MB, 2001) |
| "This study evaluated a novel drug abuse treatment, the Therapeutic Workplace." | ( Bigelow, GE; Robles, E; Silverman, K; Stitzer, ML; Svikis, D, 2001) |
| "The vulnerability of participants in Substance Abuse and Mental Health Services Administration (SAMHSA) programs is a consequence of the illnesses that they are experiencing; ethical guarantees must be in place that ensure the dignity of the persons involved in such programs." | ( McGovern, TF, 1998) |
| "Switching from non-use to substance abuse was strongly associated with worsening antiretroviral therapy use and adherence, less frequent HIV-1 RNA suppression, and blunted CD4 cell increases, compared to remaining free of substance abuse." | ( Chaisson, RE; Gebo, KA; Lucas, GM; Moore, RD, 2002) |
| "The HIV prevention programs and substance abuse treatment programs that provide services to crack-abusing women should screen for heavy drinking." | ( Flannery, BA; Lam, WK; Wechsberg, WM; Zule, WA, 2002) |
| "Treatment includes cessation of drug abuse, oral hygiene, restrictions on sugar intake, and daily fluoride supplementation." | ( Shaner, JW, 2002) |
| "While there is no shortage of substance abuse treatment programs, it's rare that such interventions focus on the particular problems involving methamphetamine abuse, a problem that new research indicates is linked to HIV transmission among men who have sex with men (MSM) across the country." | ( , 2002) |
| "Institutional treatment for legal drug dependence in Norway in 1999-2000 was not well organised, and treatment ideologies and goals were diverse." | ( Aasland, OG; Nordlie, E; Vøyvik, T, 2002) |
| "Smoking cessation treatment in substance users undergoing detoxification resulted in little or no smoking cessation advantage." | ( Alterman, A; Chychula, N; Dhopesh, V; Gariti, P; Mechanic, K; Mulvaney, F; Sacks, D; Yu, E, 2002) |
| "Several reviews of the effectiveness of drug abuse treatment have concluded that treatment works." | ( Mennemeyer, ST; Milby, JB; Nolan, K; Schumacher, JE; Wallace, D, 2002) |
| "The Therapeutic Workplace is a substance abuse treatment wherein patients are hired and paid to work in a job contingent on daily drug-free urine samples." | ( Bedient, G; Dallery, J; Robles, E; Sheppard, JM; Silverman, K; Svikis, D; Wong, CJ, 2003) |
| "Although life prevalence of substance use disorders among patients with schizophrenia is close to 50%, few studies have been carried out to date to identify an integrated pharmacological treatment for this comorbidity." | ( Potvin, S; Roy, JY; Stip, E, 2003) |
| "Alcohol, drug abuse and past medical information, including antiretroviral treatment, were obtained using research questionnaires and medical chart review in 220 HIV-1 infected drug users." | ( Burbano, X; Miguez, MJ; Morales, G; Rodriguez, A; Shor-Posner, G, 2003) |
| "This article describes psychiatric and substance dependence comorbidities, lifetime rates of infectious disease, and reported high-risk sexual behaviors for methamphetamine-dependent, gay and bisexual men at entry to outpatient drug abuse treatment in Los Angeles." | ( Peck, J; Reback, CJ; Rotheram-Fuller, E; Shoptaw, S, 2003) |
| "Comorbid drug abuse presents complications to the effective treatment of these patients because they have increased psychotic symptoms and poorer treatment compliance." | ( Weisman, RL, 2003) |
| "Forty hair samples collected from drug abusers admitted to centers for detoxification treatment were analyzed obtaining 23 positive results for opiates and/or cocaine." | ( Lopez, A; Pacifici, R; Palmi, I; Romolo, FS; Rotolo, MC, 2003) |
| "Although pain problems are prevalent in substance use disorder (SUD) patients, the special treatment needs of SUD patients with pain have not been investigated." | ( Horst, DA; Humphreys, K; Minkel, JD; Oliva, EM; Trafton, JA, 2004) |
| "When treating adults with ADHD and substance abuse, clinicians should assess the relative severity of the substance abuse, the symptoms of ADHD, and any other comorbid disorders." | ( Wilens, TE, 2004) |
| "Friends, drug abuse treatment programs, and physicians were perceived to be the most accurate sources of information about ecstasy by 45." | ( Carlson, RG; Falck, RS; Siegal, HA; Wang, J, 2004) |
| "In adolescents with substance use disorder (SUD), comorbid attention-deficit/hyperactivity disorder (ADHD) is associated with greater severity of substance abuse, conduct problems, and worse treatment outcomes." | ( Hall, SK; Kayser, A; Lohman, M; Mikulich-Gilbertson, SK; Riggs, PD, 2004) |
| "Patients with both chronic pain and substance use disorders are increasingly encountered in a variety of treatment settings." | ( Geppert, CM, 2004) |
| "In order to treat drug dependence effectively it is necessary to obtain the patient history of drug use and to evaluate and determine short-term and long-term drug use with urinalysis and hair analysis, respectively." | ( Ando, E; Hayashida, M; Nihira, M; Ohno, Y; Yamada, T, 2004) |
| "However, most patients who are drug abusers are still excluded from treatment of chronic HCV infection with interferon (IFN)-alpha." | ( Backmund, M; Heinz, A; Schaefer, M, 2004) |
| "Patients with former or present drug abuse seem more likely to discontinue treatment early." | ( Backmund, M; Heinz, A; Schaefer, M, 2004) |
| "Nonetheless, multiple substance use is the predominating pattern of cocaine use, and the different routes of administration have to be taken into account." | ( Andersson, P; Bácskai, E; Bruguera, E; Butler, S; Camposeragna, A; Fischer, G; Gerevich, J; Gossop, M; Güttinger, F; Haasen, C; Krausz, M; Manning, V; Matali, JL; Olsson, B; Pezous, AM; Primorac, A; Prinzleve, M; Rehm, J; Ryder, N; Verster, A; Zurhold, H, 2004) |
| "Studies of remission from drug dependence have most often been based on treatment samples, with limited generalizability to persons who may benefit from but never seek substance abuse treatment." | ( Alegría, M; Canino, G; Warner, LA, 2004) |
| "Implications for substance abuse research and treatment using VR to assess cessation and anticraving medications are discussed." | ( Bordnick, PS; Brooks, J; Copp, H; Ferrer, M; Graap, KM; Logue, B, 2004) |
| "Three cases of patients presenting a substance use disorder with comorbid major depression episodes are presented, who were treated with a reboxetine/escitalopram combination and who showed a rapid response of their depressive syndrome." | ( Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF, 2005) |
| "Screening and identification of substance use should be included in all treatment settings and community-based organizations serving adults living with HIV." | ( Goldstein, R; Gore-Felton, C; Johnson, M; Kirshenbaum, S; Kittel, L; Lightfoot, M; May, S; Morin, SF; Rogers, T; Rotheram-Borus, MJ; Weinhardt, L; Zadoretzky, C, 2005) |
| "We examined the association of substance abuse treatment services on hospitalization among participants in the HIV-Alcohol Longitudinal Cohort (HIV-ALC) study of HIV-infected individuals with a history of alcohol problems." | ( Horton, NJ; Meli, S; Palepu, A; Samet, JH; Tibbetts, N, 2005) |
| "We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility, 12 visits to a substance abuse counselor or mental health professional, or participation in any methadone maintenance program." | ( Horton, NJ; Meli, S; Palepu, A; Samet, JH; Tibbetts, N, 2005) |
| "Engagement in substance abuse treatment was not associated with a decrease in hospital use by HIV-infected individuals with a history of alcohol problems." | ( Horton, NJ; Meli, S; Palepu, A; Samet, JH; Tibbetts, N, 2005) |
| "Less than 14% had been in substance abuse treatment recently." | ( Carlson, RG; Draus, PJ; Falck, RS; Siegal, HA; Wang, J, 2005) |
| "Dopamine release is implicated in substance use, and both dopaminergic agonists and antagonists have been examined for the treatment of substance abuse." | ( Beard, L; Brown, ES; Garza, M; Jeffress, J; Liggin, JD, 2005) |
| "Treatment-seeking is limited in women substance abusers." | ( Basu, D; Grover, S; Irpati, AS; Mattoo, SK; Saluja, BS, 2005) |
| "Suicidal ideation and substance use during treatment were predictors of early treatment dropout among the total sample." | ( Brethen, P; Gonzales, R; McCann, MJ; Obert, JL; Rawson, RA, 2005) |
| "Adolescents tend to have shorter substance use histories therefore they often experience emergency/acute care health treatment resulting from substance use related trauma and/or overdose." | ( Burke, PJ; O'Sullivan, J; Vaughan, BL, 2005) |
| "Non-injecting substance users benefited most from the ODS in terms of withdrawal completion and ongoing treatment." | ( Curry, K; Fucito, L; O'Connor, D; Sannibale, C, 2005) |
| "Treatment of adolescent substance abusers is difficult." | ( Ahrendt, DM; Miller, MA, 2005) |
| "Neuroscientific approaches to drug addiction traditionally have been based on the premise that addiction is a process that results from brain changes that in turn result from chronic administration of drugs of abuse." | ( Galuska, CM; Wade-Galuska, T; Winger, G; Woods, JH, 2005) |
| "A questionnaire on drug dependence and risk behaviour was completed by 306 users of drug treatment services, and focus groups were conducted with 45 self-selected crack/cocaine users." | ( Harvey, I; Holland, R; Maskrey, V; Rumball, D; Vivancos, R, 2006) |
| "This article reviews recent research on drug abuse and addiction in Hispanics in which biological questions have been addressed, including work on genes, gene products (proteins), physiology and pharmacotherapy." | ( Castañeda, E; González, G; Martínez, D; Trujillo, KA, 2006) |
| "Subjects were enrolled and treated at a drug addiction outpatient clinic of the National Health System Local Unit in Milan, Italy." | ( Cocchi, L; Corrado, F; Cozzolino, E; De Chiara, M; Guglielmino, L; Marzorati, P; Silenzio, R; Vigezzi, P, 2006) |
| "This new drug abuse prevention paradigm holds great promise for efforts to reduce the nonmedical use of prescription controlled substances, including the prescription stimulants used to treat ADHD." | ( Bensinger, PB; DuPont, RL, 2006) |
| "The co-occurrence of substance use leads to poorer long- and short-term outcomes in schizophrenia and complicates the treatment of both conditions." | ( Brown, ES; Green, AI, 2006) |
| "We examined the association of substance abuse treatment with access to liver specialty care among 231 persons coinfected with HIV and hepatitis C virus (HCV) with a history of alcohol problems who were recruited and followed up in the HIV-Longitudinal Interrelationships of Viruses and Ethanol cohort study from 2001 to 2004." | ( Alperen, J; Cheng, DM; Kim, T; Nunes, D; Palepu, A; Saitz, R; Samet, JH; Vidaver, J, 2006) |
| "In light of our observation that substance abusers have poor dietary habits and the strong association between anxiety disorders and substance use disorders, the possibility that the administration of supplements of n-3 PUFAs would decrease the anxiety level of a group of substance abusers was explored." | ( Branchey, M; Buydens-Branchey, L, 2006) |
| "Referral to off-site substance abuse services treatment did not significantly predict either virologic outcome." | ( Altice, FL; Bruce, RD; Mezger, J; Smith-Rohrberg, D; Walton, M, 2006) |
| "Most substance abuse treatment facilities do not routinely treat cigarette smoking even though most of their clients smoke and many will die from tobacco-related illness." | ( Richter, KP, 2006) |
| "In a cohort of 501 drug abusers admitted to treatment in the period 1981-1991, mortality has been calculated as incidence rates." | ( Amundsen, EJ; Kielland, KB; Ødegård, E, 2007) |
| "History of drug abuse, use of depot antipsychotics and prior duration of hospitalization were positive predictors of cost of therapy." | ( Hui, HY; Law, WL; You, JH; Young, WM, 2007) |
| "A preliminary review of substance abuse treatment admission data from 2001-2005 was conducted to explore the use of methamphetamine among American Indians in treatment programs funded by Los Angeles County." | ( Clark, R; Crèvecoeur, DA; Rawson, RA; Spear, S, 2007) |
| "Compared to National Survey of Substance Abuse Treatment Services (N-SSATS), programs located in medical settings are over-represented and centers that are mental health clinics are under-represented." | ( Arfken, C; Copersino, M; Edmundson, E; Floyd, A; Forman, R; Fuller, B; Kaskutas, LA; Magruder, KM; McCarty, D; Miller, M; Nunes, EV; Sindelar, J; Wendt, WW, 2008) |
| "We examined the effects of substance abuse treatment, current versus former substance use, and hazardous/binge drinking on adherence to HAART." | ( Chander, G; Fleishman, JA; Gaist, P; Gebo, KA; Hellinger, J; Hicks, PL; Josephs, JS; Korthuis, PT; Mulvey, KP, 2007) |
| "Illicit drug abusers in a Drug Abstention and Treatment Center were recruited to complete the questionnaires and their data were compared with an age-matched control." | ( Bang-Ping, J, 2009) |
| "The Center for Substance Abuse Treatment funded the Metamphetamine Treatment Project to evaluate and compare treatment approaches for methamphetamine users." | ( Brecht, ML; Christian, DR; Galloway, GP; Huber, A; Lord, RH; Lu, TH; Marinelli-Casey, P; McCann, MJ; Reiber, C, 2007) |
| "Anxiety disorders often coexist with substance use and complicate treatment by causing non-adherence and relapse." | ( Arndt, S; Petty, F; Sattar, SP; Schultz, SK; Soundy, T, 2007) |
| "Journal of Substance Abuse Treatment 31, 385-393." | ( Brooner, RK; Burke, C; Kidorf, M; King, VL; Kolodner, K; Neufeld, KJ; Peirce, J; Stoller, KB, 2008) |
| "A typical approach to categorizing substance users for epidemiologic purposes or to identify substance use problems at treatment admission is by indicating the primary substance used and/or for which treatment is sought." | ( Brecht, ML; Evans, E; Hser, YI; Huang, D, 2008) |
| "Quetiapine is a promising treatment for substance use disorders alone or combined with other psychiatric diagnoses, such as bipolar disorder and schizophrenia." | ( Hanley, MJ; Kenna, GA, 2008) |
| "Even when controlling for substance use disorder, age at stimulant treatment initiation was significantly and positively related to the later development of antisocial personality disorder." | ( Castellanos, FX; Howell, KH; Klein, RG; Mannuzza, S; Moulton, JL; Roizen, ER; Truong, NL, 2008) |
| "Participants from an urban outpatient substance abuse treatment program were randomly assigned to receive $70, $100, $130, or $160 in either cash or a gift card for completing a follow-up assessment at 6 months post-admission (n congruent with 50 per cell)." | ( Arabia, PL; Croft, JR; Dugosh, KL; Festinger, DS; Marlowe, DB, 2008) |
| "Pain and substance abuse co-occur frequently, and each can make the other more difficult to treat." | ( Kirsh, KL; Passik, SD; Savage, SR, 2008) |
| "We compared pregnant women from a drug dependence and treatment program who were HCV antibody-positive with those who were HCV antibody-negative using the University of New Mexico Perinatal Database." | ( Arora, S; Berkley, EM; Dunkelberg, JC; Leslie, KK; Qualls, C, 2008) |
| "Comorbid anxiety and/or substance use disorder are clinically identifiable, and their presence may define distinct MDD subgroups that have more problems and worse pharmacological treatment outcomes." | ( Balasubramani, GK; Berman, SR; Davis, LL; Fava, M; Howland, RH; McGrath, PJ; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR, 2009) |
| "One understudied area of the substance abuse treatment system is correctional institutions." | ( Knudsen, HK; Leukefeld, C; Oser, CB; Staton-Tindall, M; Taxman, F, 2009) |
| "The association between substance use, rates of completion of therapy and rates of response were assessed using multivariable regression analyses." | ( Daiter, J; John-Baptiste, A; Krahn, M; Lingley, M; Nedd-Roderique, T; Teplin, D; Tomlinson, G; Varenbut, M, 2009) |
| "Efforts to increase awareness of drug abuse among elderly patients, caregivers, and health care practitioners, as well as research into how best to prevent and treat the elderly drug abuser, will be necessary to thwart what could become a significant public health problem." | ( Martin, CM, 2008) |
| "The odds of substance use and abuse were generally lower among self-treatment subtypes than other subtypes." | ( Boyd, CJ; McCabe, SE; Teter, CJ, 2009) |
| "Patients with mental illness and drug addiction should have routine screening and treatment for HCV infection to prevent associated morbidity and mortality." | ( Freedman, K; Nathanson, J, 2009) |
| "Differences in psychiatric distress and substance use (licit and illicit) were examined in methadone maintenance treatment (MMT) patients with a variety of pain experiences." | ( Barry, DT; Beitel, M; Garnet, B; Joshi, D; Rosenblum, A; Schottenfeld, RS, 2009) |
| "The risk of developing long-term substance abuse with attention deficit hyperactivity disorder, without co-morbidities, is small and may decrease with proper treatment." | ( Kuchibhatla, A; Merkel, RL, 2009) |
| "Analyses examined substance use (via the Drug Use Severity Index) and changes therein in relation to treatment and depressive symptoms." | ( Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Goldstein, BI; Mayes, T; Onorato, M; Ryan, N; Shamseddeen, W; Spirito, A; Vitiello, B; Wagner, KD; Zelazny, J, 2009) |
| "Secondary data on substance abuse treatment admissions, from 1995 through 2000, were obtained from the Department of Public Health, Community Substance Abuse Services, San Francisco, California." | ( Davis, T; Gleghorn, A; Guydish, J; Sears, C, 2009) |
| "Patients' substance use problems are a particularly understudied aspect of psychosocial variables in cancer treatment." | ( Antin, JH; Chang, G; Jones, JA; Meadows, ME; Orav, EJ, 2010) |
| "outpatient substance abuse treatment (OSAT) facilities provide HIV counseling and testing (C&T) to clients between 1995 and 2005." | ( D'Aunno, T; Pollack, HA, 2010) |
| "Twelve-week HIV and substance abuse treatment outcomes are reported as a sub-study for those selecting BPN/NLX." | ( Altice, FL; Chen, S; Springer, SA, 2010) |
| "Since 2001, the National Drug Abuse Treatment Clinical Trials Network (CTN) has worked to put the results of its trials into the hands of community treatment programs, in large part through its participation in the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative and its close involvement with the Center for Substance Abuse Treatment's Addiction Technology Transfer Centers." | ( Albright, LM; Brigham, GS; Condon, TP; Freese, TE; Gallon, S; Higgins, C; Hulsey, EG; Krom, L; Martino, S; Nugent, CD; Perl, H; Pintello, D; Storti, SA, 2010) |
| "The National Institute on Drug Abuse established the National Drug Abuse Treatment Clinical Trials Network (CTN) to conduct trials of promising substance abuse treatment interventions in diverse clinical settings and to disseminate results of these trials." | ( Abraham, AJ; Knudsen, HK; Roman, PM; Rothrauff, TC, 2010) |
| "BPD-associated symptoms, such as substance abuse, anorexia, self-injury, depersonalization, and sexual overstimulation, can be treated successfully with opioid receptor antagonists." | ( Bandelow, B; Falkai, P; Schmahl, C; Wedekind, D, 2010) |
| "There is an urgent need to treat drug addiction and ADHD symptoms in order to reduce offending among the most persistent offenders." | ( Gudjonsson, GH; Wells, J; Young, S, 2011) |
| "A randomized trial of substance abuse treatment programs tested whether "enhanced profiles," consisting of feedback and coaching about performance indicators, improved the performance of residential, methadone, and detoxification programs." | ( Daley, M; Dunigan, R; Horgan, C; Perloff, J; Reif, S; Shepard, DS; Siembab, L; Tompkins, C, 2011) |
| "Treatment for drug addiction in China can take place in mandatory detoxification centers (MDC), voluntary detoxification centers (VDC), or at outreach programs located in the community." | ( Brown, K; Dong, R; Jin, X; Li, G; Smith, K; Wang, H; Wang, N, 2011) |
| "With rates of drug abuse and misuse on the rise, clinicians must remain especially attentive to drug abusers' verbal and nonverbal cues, and be familiar with treating perioperative complications if they arise." | ( Cone, JD; Harrington, MA; Kelley, SS; Payne, WG; Prince, MD; Smith, DJ, 2011) |
| "Acupuncture has been used to treat drug addiction by nicotine, alcohol, cocaine and morphine." | ( Kim, HW; Kim, KW; Kwon, YB; Li, J, 2011) |
| "Addiction to multiple abused drugs (polydrug addiction) is now commonplace and presents a treatment challenge, given the limited pharmacotherapies currently approved." | ( Zaveri, NT, 2011) |
| "Impulsivity is associated with substance use; however, to date, impulsivity has not been characterized among a sample of homeless, non-treatment seeking, substance-dependent men who have sex with men (MSM)." | ( Amass, L; Dierst-Davies, R; Kamien, JB; Nuño, M; Peck, JA; Reback, CJ, 2011) |
| "The use of medications to treat substance use disorders (SUDs) has emerged as a potentially central part of the treatment armamentarium." | ( Abraham, AJ; Knudsen, HK; Roman, PM, 2011) |
| "Only 35% of patients with SUD received substance abuse treatment." | ( Dobscha, SK; Duckart, JP; Morasco, BJ, 2011) |
| "Poly-substance use before intake into treatment, high levels of conduct disorder on SCID screen and younger age at intake had a negative impact on retention and abstinence." | ( Fridell, M; Hesse, M; Öhlin, L; Tätting, P, 2011) |
| "Relapse is a hallmark of drug addiction and a daunting challenge facing the clinical treatment of the disease." | ( Sun, W, 2011) |
| "There was no difference in days of substance use or ADHD symptom outcomes over time in adolescents with MDD or those without MDD treated with OROS-MPH or placebo." | ( Mikulich-Gilbertson, SK; Min, SJ; Riggs, PD; Tamm, L; Trello-Rishel, K; Warden, D; Winhusen, T, 2012) |
| "Aggressive, suicidal, substance use and sexual risk behaviors were measured using a self-administered, multi-item, validated questionnaire in the local vernacular." | ( Biswas, AB; Mukhopadhyay, DK; Mukhopadhyay, S; Sinhababu, A, 2012) |
| "Illicit drug users attending a drug dependence treatment clinic in Delhi (n=126)." | ( Dhawan, A; Gupta, T; Mathur, VP; Shah, N, 2012) |
| "The co-occurrence of substance use disorder (SUD) and major depressive disorder (MDD) is common and is often thought to impair response to antidepressant therapy." | ( Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S, 2012) |
| "Culturally sensitive substance abuse treatment and increased funding for treatment are major health issues for this population." | ( Dennis, MK; Momper, SL, 2012) |
| "Our sample consisted of 49 polysubstance users enrolled in residential treatment." | ( Fernández-Serrano, MJ; Gómez-Río, M; Moreno-López, L; Pérez-García, M; Rodríguez-Fernández, A; Stamatakis, EA; Verdejo-García, A, 2012) |
| "To determine the prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment, via cross sectional survey." | ( Barry, DT; Cutter, CJ; Dinh, A; Fiellin, DA; Joy, MT; Savant, JD; Schottenfeld, RS, 2013) |
| "Mood and substance use comorbidity is prevalent among patients seeking primary care office-based buprenorphine/naloxone treatment." | ( Barry, DT; Cutter, CJ; Dinh, A; Fiellin, DA; Joy, MT; Savant, JD; Schottenfeld, RS, 2013) |
| "The data include 2920 clients from 57 substance abuse treatment programs." | ( Andrews, CM; Cao, D; Marsh, JC; Shin, HC, 2013) |
| "A promising strategy for drug abuse treatment is to accelerate the drug metabolism by administration of a drug-metabolizing enzyme." | ( Zhan, CG; Zheng, F, 2012) |
| "With the increasing epidemic of HIV and substance use (SU) worldwide, it is important to understand the impact of these conditions on cognition, which may affect quality of life and possibly decrease adherence to treatment." | ( Dobs, AS; Selnes, OA; Wisniewski, AB; Xu, X; Zilbermint, MF, 2013) |
| "The National Drug Dependence Treatment Centre (NDDTC) is a part of the All India Institute of Medical Sciences, a premier autonomous medical university in India." | ( Chopra, A; Dhawan, A; Ray, R, 2013) |
| "Conventional treatments for drug addiction mainly seek to use small molecule agonists or antagonists to target the drug receptors in the brain, but unfortunately it is difficult to find a similar small molecule for the treatment of methamphetamine dependence." | ( Chen, CH; Chen, YH, 2013) |
| "The effect of active substance use on interferon (IFN)-responsiveness and therapy efficacy is not well understood." | ( Boonstra, A; de Knegt, RJ; Groothuismink, ZM; Hotho, DM; Janssen, HL; Kreefft, K, 2013) |
| "Demographics and drug abuse characteristics at enrollment, including gender, age, employment status, family relationship, injection, needle sharing, criminal behavior, contacts with drug users, MMT daily dosage and family members receiving MMT were not significantly associated with treatment retention (P > 0." | ( Cao, XB; Li, JH; Luo, W; Pang, L; Rou, KM; Wang, CH; Wu, ZY; Yin, WY, 2012) |
| "Multivariate analysis showed that the substance use involvement of network members was higher in those patients still using heroin, even when other treatment factors were controlled for." | ( Chohan, G; Copello, A; Day, E; George, S; Grewal, P; Haque, S; Karia, M; Roche, J, 2013) |
| "Treatment was followed by less substance use/abuse and craving in comorbid bipolar-SUD patients." | ( Ambrosi, E; Brugnoli, R; Caloro, M; Del Casale, A; Ferracuti, S; Ghaemi, SN; Girardi, P; Kotzalidis, GD; Koukopoulos, AE; Manfredi, G; Mazzarini, L; Pacchiarotti, I; Pucci, D; Sani, G; Savoja, V; Simonetti, A; Tamorri, SM; Telesforo, CL; Vergne, DE; Vöhringer, P, 2013) |
| "Relapse of drug abuse after abstinence is a major challenge to the treatment of addicts." | ( Miyamoto, Y; Muramatsu, S; Nabeshima, T; Nitta, A; Ozawa, K; Yamada, K; Yan, Y, 2013) |
| "A substantial number of substance abusers entering outpatient psychosocial counseling treatment are referred from the criminal justice (CJ) system." | ( DeFulio, A; Nuzzo, P; Petry, N; Roll, J; Schwartz, RP; Stabile, P; Stitzer, M, 2013) |
| "Thirty HIV-negative substance users were individually matched to 30 HIV-positive substance users on relevant medical and demographic factors, including reading level and methadone therapy status." | ( Byrd, DA; Elliott, K; Lighty, Q; Mindt, MR; Mintz, L; Morgello, S; Robinson-Papp, J, 2013) |
| "Given that substance abuse among persons with disabilities is markedly more prevalent than among other persons for most substances, findings indicate a need for accessible, targeted prevention programs and a potentially overwhelming demand for accessible SA treatment services and facilities." | ( Glazier, RE; Kling, RN, 2013) |
| "Traditional substance abuse therapeutic programs too frequently focus only on treatment of alcohol or other drugs rather than including treatment for tobacco dependence." | ( Coscas, S; Karila, L; Lowenstein, W; Petit, A; Reynaud, M; Zarmdini, R, 2013) |
| "MDMA may also help treat substance abuse based on shared features with psychedelic compounds and recent reports indicating that MDMAassisted psychotherapy can reduce symptoms of PTSD." | ( Jerome, L; Schuster, S; Yazar-Klosinski, BB, 2013) |
| "Examine the severity of club drug dependence and perceived need for treatment, and further identify their determinants among a sample of club drug users in Shanghai, China." | ( Detels, R; Ding, Y; Gao, M; He, N; Shoptaw, S, 2014) |
| "Many adolescents with substance use problems show poor response to evidence-based treatments." | ( Budney, AJ; Elton, A; James, GA; Kilts, CD; Ryan, SR; Stanger, C, 2013) |
| "Thirty adolescents being treated for substance abuse completed a DD task optimized to balance choices of immediate versus delayed rewards, and a control condition accounted for activation during magnitude valuation." | ( Budney, AJ; Elton, A; James, GA; Kilts, CD; Ryan, SR; Stanger, C, 2013) |
| "In the self-administration model of drug abuse, Ro 61-8048 reduced the rewarding effects of THC and the synthetic cannabinoid WIN 55,212-2 in squirrel monkeys and rats, respectively, and it also prevented relapse to drug-seeking induced by reexposure to cannabinoids or cannabinoid-associated cues." | ( Barnes, C; Bergman, J; Ferré, S; Fratta, W; Goldberg, SR; Justinova, Z; Kangas, BD; Mascia, P; Panlilio, LV; Parashos, A; Pistis, M; Redhi, GH; Scherma, M; Schwarcz, R; Secci, ME; Solinas, M; Tanda, G; Wu, HQ; Zara, T, 2013) |
| "Developing additive substance abuse treatment programs for pregnant women is socially important and can help ensure the health of babies, prevent subsequent developmental and behavioral problems (i." | ( Biziuk, M; Namieśnik, J; Narkowicz, S; Polkowska, Z; Płotka, J, 2014) |
| "To examine the prevalence of substance use among treatment naïve patients with first episode psychosis presenting to a psychiatry outpatient clinic in India." | ( Chand, P; Murthy, P; Thirthalli, J, 2014) |
| "To find out the pattern of substance use, relapse rate, its association with various socio-demographic factors and treatment related issues." | ( Manna, N; Mukherjee, A; Sanyal, S; Sau, M, 2013) |
| "Subjects were selected from a substance dependence treatment-cohort and assessed for: (a) high ES counts, (b) maximum prior period of abstinence, (c) quality of life during that period, and (d) shortest time from prior relapse to restarting treatment." | ( Benegal, V; Chakraborty, V; Jose, SP; Kandavel, T; Kesavan, M; Narayanaswamy, JC; Sankar, D; Viswanath, B, 2013) |
| "Although human drug abuse can be hardly modelling under experimental circumstances, our constant, relatively moderate dose morphine treatment administered once daily during the whole pregnancy and lactation resulted in several subtle behavioural changes in dams." | ( Al-Khrasani, M; Fürst, Z; Gyarmati, Z; Király, KP; Riba, P; Sobor, M; Timár, J, 2013) |
| "The objective was to study substance abuse, infectious disease, and patient outcomes (retention and substance abuse abstinence) over 2 decades in a large methadone maintenance treatment (MMT) facility within a tertiary-referral medical center." | ( Adelson, M; Peles, E; Schreiber, S, 2014) |
| "Self-report of past 6 month substance use was evaluated for 21 different substances by routes of administration (ROA)." | ( Keen, L; Latimer, WW; Rose, J; Trenz, RC; Whitehead, NE, 2014) |
| "Relapse outcomes from the Drug Addiction Treatment Outcome Study (DATOS; n = 1738) and HTC (n = 224) were compared for a 12-month period." | ( Blum, K; Braverman, ER; Giordano, J; Han, D; Madigan, MA; Oscar-Berman, M; Schoenthaler, SJ, 2014) |
| "Individuals with substance use disorders (SUDs) experience increased smoking-related morbidity and mortality but severely compromised smoking treatment benefits." | ( Alessi, SM; Petry, NM, 2014) |
| "Drug treatments used in substance use disorders are not effective in all patients." | ( Cohen, J; Dervaux, A; Laqueille, X, 2014) |
| "A potential new treatment for drug addiction is immunization with vaccines that induce antibodies that can abrogate the addictive effects of the drug of abuse." | ( Alving, CR; Antoline, JF; Boutaghou, MN; Iyer, MR; Jacobson, AE; Jalah, R; Li, F; Matyas, GR; Rice, KC; Torres, OB, 2014) |
| "Patients' problematic substance use prevalence and effects were explored in relation to internet-based cognitive behavioral therapy (ICBT) outcomes for depression, panic disorder and social anxiety disorder." | ( Andersson, C; Berman, AH; Gajecki, M; Hedman, E; Lindefors, N; Ljótsson, B; Rück, C; Sinadinovic, K, 2014) |
| "Problematic substance use does not preclude ICBT treatment but can worsen outcomes, particularly problematic alcohol use for panic disorder patients and hazardous drug use for social anxiety patients." | ( Andersson, C; Berman, AH; Gajecki, M; Hedman, E; Lindefors, N; Ljótsson, B; Rück, C; Sinadinovic, K, 2014) |
| "Recent substance abuse research indicates gender differences in the substance-related epidemiology, biological responses, progression to dependence, medical consequences and treatments." | ( Chen, WY; Huang, MC; Lin, SK, 2014) |
| "Medications for the treatment of substance use disorders are effective yet underutilized." | ( Friedmann, PD; Park, TW, 2014) |
| "While anthropological inquiries of substance abuse treatment have mainly focused on providing the users perspectives on the (ab)use or unraveling the conflicts and negotiations between users and staff, the present article argues for the merits of paying attention to the spatial dimensions of substance abuse treatment." | ( Schepelern Johansen, B; Schepelern Johansen, K, 2015) |
| "Although substance abuse is considered a way of life in them, such patients rarely seek treatment because of the stigma and fear of discrimination." | ( Deb, KS; Elawadhi, D; Goyal, S; Kaw, N, 2014) |
| "Smokers with substance use disorders have very low smoking cessation rates so identifying predictors of smoking treatment response is particularly important for these difficult-to-treat smokers." | ( Colby, SM; Kahler, CW; Martin, RA; Rohsenow, DJ; Sirota, AD; Tidey, JW, 2015) |
| "In addition, insight into substance abuse problems and motivation to participate in further treatment slightly declined in those using "dappou drugs," while there was a significant increase reported by the patients using MAP." | ( Hikitsuchi, E; Imamura, F; Kato, T; Kawachi, H; Matsumoto, T; Takano, A; Tanibuchi, Y; Wada, K; Wakabayashi, A, 2014) |
| "Available treatments for addiction and substance abuse in Ukraine have been shaped by the economic, political, and social shifts that have followed the country's independence." | ( Carroll, JJ, 2016) |
| "This mixed-methods study describes the substance use histories, addiction symptoms, and treatment experiences of a community-recruited sample of methamphetamine users in Cape Town." | ( Kimani, S; Lion, RR; Meade, CS; Myers, B; Pieterse, D; Skinner, D; Towe, SL; Watt, MH, 2015) |
| "Nearly half of individuals with substance use disorders relapse in the year after treatment." | ( Ball, TM; Gowin, JL; Paulus, MP; Tapert, SF; Wittmann, M, 2015) |
| "The development of new treatments for substance use disorders requires identification of targetable molecular mechanisms." | ( Kalivas, PW; Roberts-Wolfe, DJ, 2015) |
| "Perceived stigma towards substance use may determine family members' willingness to help in the treatment process of a substance user." | ( Basu, D; Gupta, S; Mattoo, SK; Nebhinani, N; Parakh, P; Sarkar, S, 2015) |
| "Despite the serious consequences of substance use, only a few therapies are effective in treating substance use disorders, thus highlighting a need for improved treatment practices." | ( Bauer, IE; Graham, DP; Nielsen, DA; Patriquin, MA; Soares, JC, 2015) |
| "To improve outcomes for people with substance dependence and HIV infection or at risk for HIV infection, patients were enrolled in a primary care-based addiction treatment program from 2008-2012 that included a comprehensive substance use assessment, individual and group counseling, addiction pharmacotherapy and case management." | ( Chaisson, C; Drainoni, ML; Palmisano, J; Raj, A; Samet, JH; Sorensen-Alawad, A; Walley, AY, 2015) |
| "Global treatment of drug addiction costs society billions of dollars annually, but current psychopharmacological therapies have not been successful at desired rates." | ( Choi, JS; Li, MD; Nesil, T; Wingo, T, 2016) |
| "Participants were 255 substance users entering outpatient treatment who received the therapeutic educational system (TES), in addition to usual care counseling." | ( Campbell, AN; Cunningham, C; Hu, MC; Nunes, EV; Pavlicova, M; Stitzer, M, 2017) |
| "Studies of buspirone for substance use disorders have had disappointing outcomes, although it may be useful for treating coexisting anxiety and one controlled study suggested efficacy for heroin detoxification." | ( Howland, RH, 2015) |
| "Among patients with a current substance use disorder (SUD), those receiving SUD treatment had a lower risk of mortality than untreated patients (HR 0." | ( Becker, WC; Crystal, S; Edelman, EJ; Fiellin, DA; Gaither, JR; Gordon, K; Goulet, JL; Justice, AC; Kerns, RD; Rimland, D; Skanderson, M, 2016) |
| "Biochemical verification of substance use is needed in high risk populations involved in studies not directly related to the treatment of substance use, especially in populations with high threat of stigmatization." | ( Clark, CB; Cropsey, KL; Li, Y; Zyambo, CM, 2016) |
| "Patients with both drug abuse and a psychiatric disease - dual diagnosis - suffer decreased compliance to treatment and decreased life expectancy compared with single-diagnosis patients." | ( Banner, J; Kruckow, L; Linnet, K, 2016) |
| "Patients with a history of substance use disorder (SUD) are more likely to be prescribed opioid medications for chronic pain than patients without an SUD history; however, little is known about prescription opioid therapy in populations composed exclusively of patients with SUD." | ( Dobscha, SK; Lovejoy, TI; Morasco, BJ; Turk, DC; Weimer, MB, 2016) |
| "Later onset, lesser duration of substance use, not currently employed/attending school, absence of psychiatric illness and using cannabis were associated with drop out from outpatient treatment." | ( Arya, S; Gupta, R; Rathee, S; Rawat, V, 2016) |
| "This topic has implications for drug use disorders and addiction, as treatments that target the balance between the different circuits may be useful for reducing excessive substance use." | ( Gremel, CM; Lovinger, DM, 2017) |
| "Theoretically, substance use disorder (SUD) treatment that matches an individual's etiology and/or maintaining factors should be more effective than a treatment that does not directly address these factors." | ( Bountress, KE; Gray, KM; Tomko, RL, 2016) |
| "Treatment for substance use disorders (SUD) provides an opportunity to use voucher-based treatment for smoking." | ( Colby, SM; Martin, RA; Monti, PM; Rohsenow, DJ; Tidey, JW, 2017) |
| "Evidence based treatment for Substance use disorders (SUD) includes psychotherapy and pharmacotherapy." | ( de Veen, BT; Homberg, JR; Schellekens, AF; Verheij, MM, 2017) |
| "In this special issue of the Journal of Substance Abuse Treatment, we present 16 articles representing the latest research in efficacy, implementation, and technological advances related to CM." | ( Rash, CJ; Stitzer, M; Weinstock, J, 2017) |
| "Although individuals in substance use disorders (SUD) treatment continue to smoke at high rates, regulatory, policy and programming changes promoting tobacco cessation are being implemented and some patients quit successfully." | ( Campbell, BK; Guydish, J; Le, T; Tajima, B, 2017) |
| "Focused attention on the prescription drug abuse epidemic needs to include evidence-based training for clinicians who manage patients with pain to facilitate accurate screening with consideration of comorbid conditions, diagnosis, selection of the appropriate treatment regimen, and focused monitoring of adherence to the established course of therapy." | ( Midgley, M, 2017) |
| "The DA program addresses Maine's prescription drug abuse epidemic with innovative resources that provide access to drug arrest data for health care providers to identify and respond to patients at risk for overdose, those engaged in illegal prescription drug distribution, and those who need treatment." | ( Desrosiers, CE; Fisher, HC; McCall, KL; Nichols, SD; Piper, BJ, 2017) |
| "Comorbid substance abuse is known to blunt response to treatment for underlying psychiatric disorders, but it has not been investigated in schizophrenia when comparing the effects of long-acting injectable antipsychotics with those of oral antipsychotics." | ( Alphs, L; Bermak, J; Lynn Starr, H; Mao, L; Rodriguez, S, 2018) |
| "In the substance abuse cohort, treatment failure was observed in 56." | ( Alphs, L; Bermak, J; Lynn Starr, H; Mao, L; Rodriguez, S, 2018) |
| "We evaluate whether secondary substance use modifies the association between treatment and primary drug use among primary heroin, cocaine and methamphetamine (MA) users." | ( Evans, E; Hser, YI; Huang, D; Krebs, E; Liu, L; Min, JE; Nosyk, B; Wang, L, 2017) |
| "In the absence of secondary substance use, treatment was strongly associated with decreased odds of primary drug use (adjusted odds ratios (aORs): 0." | ( Evans, E; Hser, YI; Huang, D; Krebs, E; Liu, L; Min, JE; Nosyk, B; Wang, L, 2017) |
| "This study demonstrates secondary substance use moderates the temporal associations between treatment and primary drug use among primary heroin, MA and cocaine users." | ( Evans, E; Hser, YI; Huang, D; Krebs, E; Liu, L; Min, JE; Nosyk, B; Wang, L, 2017) |
| "In the field of NeuroHIV and drug addiction, EVs hold the potential to serve as biomarkers of cognitive dysfunction, targets of therapy, and as vehicles for therapeutic delivery of agents that can ameliorate disease pathogenesis." | ( Bond, VC; Buch, S; Haughey, N; Hu, G; Kashanchi, F; Pulliam, L; Witwer, KW; Yelamanchili, S, 2017) |
| "Co-occurrence between drug abuse and mental health problems highlights the need of highly specialized competence in SUD treatment." | ( Lauritzen, G; Nordfjærn, T, 2018) |
| "Since 40-60% of patients treated for substance use disorder return to active substance use within a year following treatment discharge, alleviating the vulnerability to relapse is regarded as the most promising avenue for addiction therapy." | ( Kalivas, P; Neuhofer, D, 2018) |
| "The use of family history of substance use disorder information as part of a comprehensive assessment of chronic pain can provide important data for treatment." | ( Evans, M; Pestka, EL, 2018) |
| "Cognitions associated with craving and substance use are important contributors for the psychological theories of Substance use disorders (SUD), as they may affect the course and treatment." | ( Arikan, Z; Eser, HY; Kotan, VO; Küçükkarapınar, M; Tarhan, R; Yalcinay-Inan, M, 2018) |
| "Patients in RL + TAU attended more substance use disorder treatment and self-help group sessions during treatment than those in TAU." | ( Barry, DT; Buono, FD; Fiellin, DA; Lloyd, DP; Moore, BA; Printz, DMB, 2019) |
| "Searching for the keywords drug abuse, alcoholism, drug effects and drug addiction treatment during the period 1976-2017 produced 728 theses." | ( Bueno Cañigral, FJ; Castelló-Cogollos, L; Valderrama Zurián, JC, 2019) |
| "Components of substance use disorder (SUD) treatment have been shown to reduce inpatient and emergency department (ED) utilization." | ( Chang, Y; Erwin, A; Herman, GE; Metlay, JP; Regan, S; Rigotti, NA; Wakeman, SE, 2019) |
| "Though substance use is a known risk factor for self-discharge, patients self-discharging during treatment for acute poisoning have not previously been described." | ( Brekke, M; Ekeberg, Ø; Jacobsen, D; Vallersnes, OM, 2019) |
| "Lastly, substance abuse became a major issue involving the cooperation of experts on all levels to devise better treatment programs and prevent abuse-based accidents, injury and death." | ( Coskunol, H; Moulahoum, H; Timur, S; Zihnioglu, F, 2019) |
| "Cognitive impairments in substance use disorder predict treatment outcome and are assumed to differ between substances." | ( Bruijnen, CJWH; DE Jong, CAJ; Dijkstra, BAG; Kessels, RPC; Markus, W; VanDerNagel, JEL; Walvoort, SJW, 2019) |
| "Pathological substance use disorders represent a major public health crisis with limited effective treatment options." | ( Kiraly, DD; Meckel, KR, 2019) |
| "This study aimed to identify changes in substance abuse and sexual practices among MMT patients after treatment in three Vietnamese mountainous provinces." | ( Dam, NV; Do, HN; Doan, LP; Fleming, M; Ho, CS; Ho, MT; Ho, RC; Latkin, C; Nguyen, TMT; Tran, BX; Vu, GT; Vuong, QH; Vuong, TT, 2019) |
| "Understanding trends in substance use by gender among jail-based treatment program participants can inform policies and programs tailored to this population." | ( Bello, JK; Hearing, C; Linhorst, D; Salas, J; Weinstock, J, 2020) |
| "The present study examines substance abuse treatment provider key informants' experiences with gabapentin prescribed to clients in treatment." | ( Buttram, ME; Cicero, TJ; Ellis, MS; Kurtz, SP, 2019) |
| "Evaluation of costs and benefits of substance use treatment programs through a standard economic framework is necessary for optimal policy making." | ( Ahmadian Moghaddam, S; Mazyaki, A; Razaghi, EM, 2019) |
| "Sociodemographic as well as substance use, social-structural, addiction treatment, and HIV clinical factors were evaluated as predictors of viral rebound (VL > 1000 copies/mL)." | ( Adams, JW; Barrios, R; Marshall, BDL; Milloy, MJ; Mohd Salleh, NA; Nolan, S, 2020) |
| "Using Substance Abuse and Mental Health Services Administration (SAMHSA)'s Treatment Episode Data Set (TEDS), this study presents the prevalence of treatment for veterans seeking initial admission into publicly funded non-VHA SUD treatment centers for years 2011-2016." | ( Arndt, S; Jones, D; Lund, BC; Turvey, CL, 2020) |
| "Despite progress in understanding substance use disorders, challenges remain in their treatment." | ( Frey Ii, WH; Hanson, LR; Kashyap, B, 2020) |
| "Low initiation rates for substance use treatment after a NFOO indicate a need to address patient, provider, and system barriers." | ( Campbell, CI; Karmali, RN; Ray, GT; Rubinstein, AL; Sterling, SA; Weisner, CM, 2020) |
| "The treatment of substance use disorders has always been challenging because multiple neurotransmitters mediate addiction." | ( Kosten, TR; Xu, A, 2021) |
| "The NIDA National Drug Abuse Treatment Clinical Trials Network (NIDA CTN) is devoted to the development of effective interventions for people who use substances across a variety of populations." | ( Burlew, AK; Hatch-Maillette, M; Lanaway, D; McCuistian, C; Shambley-Ebron, D, 2020) |
| "In a state-funded substance use treatment program, we added biological measures, including urinary cotinine and exhaled carbon monoxide to self-report measures to assess recent and lifetime tobacco use." | ( Broster, LS; Guenthner, G; Luo, AY; Martin, CA; Meadows, AL, 2020) |
| "Chemical approaches to illicit drug abuse treatment options, particularly for opioid use disorder, are also discussed." | ( Carroll, FI; Lewin, AH; Mascarella, SW; Reddy, PA; Seltzman, HH, 2021) |
| "To understand the role of comorbid substance use disorders (SUDs), or polysubstance use, in the treatment of opioid use disorder (OUD), this study compared patients with OUD only to those with additional SUDs and examined association with OUD treatment receipt." | ( Blow, FC; Bohnert, ASB; Gordon, AJ; Ignacio, RV; Ilgen, MA; Kim, HM; Lin, LA, 2021) |
| "Despite the higher likelihood of a substance use disorder clinic visit, having a non-opioid substance use disorder is associated with lower likelihood of buprenorphine treatment, suggesting the importance of addressing polysubstance use within efforts to expand treatment for opioid use disorder." | ( Blow, FC; Bohnert, ASB; Gordon, AJ; Ignacio, RV; Ilgen, MA; Kim, HM; Lin, LA, 2021) |
| "Treatment of substance use should be better incorporated into the management of HIV, including a focus on potential medication/substance interactions." | ( Justice, AC; Womack, JA, 2020) |
| "We included all patients treated for substance abuse poisoning with benzodiazepines and/or z-hypnotics at the Oslo Accident and Emergency Outpatient Clinic from 1 October 2013 to 30 September 2015." | ( Andersson, JA; Brekke, M; Vallersnes, OM, 2020) |
| "Among those with recent drug dependence, treatment was more likely among those with HIV (adjusted odds ratio [aOR] 1." | ( Alavi, M; Amin, J; Degenhardt, L; Dore, GJ; George, J; Grebely, J; Hajarizadeh, B; Janjua, NZ; Krajden, M; Law, M; Matthews, GV; Tillakeratne, S; Valerio, H, 2021) |
| "Trends show increased substance use among adults, yet little research on general population samples has examined differential patterns of licit and illicit substance use that can inform prevention and treatment efforts." | ( Green, HD; Huang, W; Pollard, MS; Tucker, JS, 2021) |
| "Causes of death related to substance use and mental health were significantly higher than other causes of death, highlighting the importance of integrated treatment and substance use services." | ( Bossarte, RM; Brumage, M; Karras, E; Lilly, C; Warfield, S, 2021) |
| "Similar results were found for other substance abuse treatment admissions (cocaine (β = 0." | ( Azagba, S; Qeadan, F; Shan, L; Wolfson, M, 2021) |
| "Treatment for substance use of certain drugs and alcohol should remain a priority even during economic downturns." | ( Azagba, S; Qeadan, F; Shan, L; Wolfson, M, 2021) |
| "The estimated annual prevalence of drug use disorders is as high as 3%, underpinning the need to continually develop more effective treatments." | ( Gallo, AT; Hulse, G, 2021) |
| "The primary outcome of interest was substance use treatment completion defined as any planned discharge from treatment, including transfers to other facilities." | ( Daly, M; Gargano, LM, 2021) |
| "Studies of acupuncture effects on drug addiction are intriguing in light of the fact that acupuncture can be used as a convenient therapeutic intervention for treating drug addiction by direct activation of brain pathway." | ( Kim, HY; Lee, BH; Lee, MY; Yang, CH, 2021) |
| "The authors assessed substance use, misuse, and substance use disorders, as well as the receipt of treatment for substance use disorders, among adolescent and young adult (AYA) cancer survivors." | ( Cummings, JR; Effinger, KE; Ji, X; Mertens, AC; Wen, H, 2021) |
| "Regression models were used to link substance use profiles to high school graduation, criminal convictions, personal and household earnings, welfare receipt and partnership from age 19-37 years, obtained from administrative records." | ( Brousseau-Paradis, C; Castellanos-Ryan, N; Chadi, N; Côté, SM; Nagin, D; Orri, M; Séguin, JR; Tremblay, RE; Vergunst, F; Vitaro, F, 2022) |
| "The taboo culture surrounding substance use-mistrust, shame and macho culture-frustrates timely medical/psychological treatment of Moroccan-Dutch problematic nitrous oxide users." | ( Nabben, T; van Amsterdam, J; Weijs, J, 2021) |
| "Providers' consideration of polysubstance use patterns during treatment may assist in mitigating adverse outcomes for patients postrelease." | ( Bunting, AM; Knudsen, HK; Oser, CB; Staton, M, 2021) |
| "These patients often have problems with substance use, but it remains unclear whether the risk of substance misuse is influenced by SSRI treatment." | ( Chang, Z; Khemiri, L; Lagerberg, T; Larsson, H; Latvala, A; Lichtenstein, P; Suvisaari, J; Virtanen, S, 2022) |
| "The deleterious effects of the drug addiction epidemic are compounded by treatment strategies that are only marginally efficacious." | ( Abulseoud, OA; Angebrandt, A; Montemitro, C; Pettorruso, M; Wang, TY, 2021) |
| "Data from the 2019 National Survey of Substance Abuse Treatment Services (N-SSATS) were also used to characterize medication use among AUD clients across different treatment service settings." | ( English, K; Gu, LY; Madden, EF; Mensah, NA; Qeadan, F; Venner, KL, 2021) |
| "Recovery from substance use can be facilitated by health care providers through use of harm reduction strategies, referrals to treatment, and prescribing medications when applicable." | ( Worley, J, 2021) |
| "PEH had greater frequency of primary substance use prior to entering treatment, greater ER and hospital utilization, more criminal justice involvement, and greater prevalence of mental health diagnoses and unemployment." | ( Bass, B; Padwa, H; Urada, D, 2022) |
| "There is no effective treatment for substance use disorders such as addiction, and this review aims to describe preclinical and clinical investigations into the effects of CBD in various models of opioid, psychostimulant, cannabis, alcohol, and nicotine abuse." | ( Haghparast, A; Iezzi, D; Karimi-Haghighi, S; Manzoni, O; Razavi, Y; Scheyer, AF, 2022) |
| "The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco, and even symptomatic for stimulants and cannabinoids, thus, new more effective treatment strategies are researched." | ( Certilina, A; Charalambous, C; Khryakova, A; Lapka, M; Šlamberová, R; Sustkova-Fiserova, M, 2022) |
| "Comorbid substance abuse should be assessed and treated." | ( Kimura, T; Matsumoto, T; Tamakoshi, A; Yamamoto, T, 2022) |
| "While substance use disorders (SUD) disproportionately impact people with HIV (PWH), HIV clinics inconsistently provide evidence-based medications for addiction treatment (MAT)." | ( Chan, PA; Cornman, DH; Doernberg, M; Edelman, EJ; Fiellin, DA; Morford, KL; Muvvala, SB; Porter, E; Virata, M; Yager, JE, 2022) |
| "Facilitators included recognition of substance use as a threat to overall health, integrated care from HIV clinicians, and support for addiction treatment from peers with lived experience." | ( Chan, PA; Cornman, DH; Doernberg, M; Edelman, EJ; Fiellin, DA; Morford, KL; Muvvala, SB; Porter, E; Virata, M; Yager, JE, 2022) |
| "Screening for substance use in hospitalized HF patients as well as timely referral for treatment are important to prevent HF readmissions." | ( Balla, S; Bianco, C; Bolton, AR; Gonuguntla, K; Kumar, A; Li, S; Thyagaturu, HS, 2023) |
| "YWH with defined substance use (n = 54) receiving similar antiretroviral therapy (ART) were assigned to one of four analysis groups: YWH with detectable plasma HIV-1 (> 50 RNA copies/ml) who did not use substances (H+V+S-), and YWH with undetectable plasma HIV-1 who did not use substances (H+V-S-), or used marijuana alone (H+V-S+[M]), or marijuana in combination with tobacco (H+V-S+[M/T])." | ( Borkar, SA; Chang, KF; De Paris, K; Dinasarapu, AR; Goodenow, MM; Kim-Chang, JJ; Sleasman, JW; Yin, L, 2022) |
| "Data on the order and timing of polysubstance use at the hourly level will improve our understanding of the implications of sequential and simultaneous use patterns, which can help inform treatment and prevention efforts." | ( Cottler, LB; Fitzgerald, ND; Knackstedt, L; Liu, Y; Setlow, B; Striley, CW; Wang, A, 2022) |
| "Given the staggering society costs of substance use disorders, including the mortality caused by tobacco smoking, it is critical that public funding be made available for scientists to follow up on promising early findings of classic psychedelics in addiction treatment." | ( Johnson, MW, 2022) |
| "People with substance use disorders (SUDs) frequently present to treatment with polysubstance use and mental health comorbidities." | ( Carlyle, M; Chan, G; Hides, L; Mefodeva, V; Walter, Z, 2022) |
| "There appear to be high levels of polysubstance use among young people entering substance use treatment in Australia." | ( Carlyle, M; Chan, G; Hides, L; Mefodeva, V; Walter, Z, 2022) |
| "Connecting patients to treatment for a substance use disorder (SUD) that satisfies their needs is often complicated by confounding factors." | ( Clements, CW; Davies, TH; Egleton, R; Fresch, C; Lamichhane, R; Maddox-Rooper, TR; Sklioutouskaya-Lopez, K; Sturgill, T, 2022) |
| "Understanding the risks for substance use disorders (SUDs) and how to diagnose and treat is essential to the safe and effective treatment of patients with chronic noncancer pain (CNCP)." | ( Eagen, K; Kellum, R; Rabson, L, 2022) |
| "Dopamine has a well-established role in substance use disorders, including TUD, and there has been a long-standing interest in developing agents that target the dopaminergic system to treat substance use disorders." | ( Butler, K; Di Ciano, P; Le Foll, B, 2023) |
| "The causes of substance use disorders (SUDs) are largely unknown and the effectiveness of their treatments is limited." | ( Boness, CL; DeYoung, CG; Keyser-Marcus, L; Kotov, R; Krueger, RF; Latzman, RD; Moeller, FG; Ramey, T; Watts, AL; Zald, DH, 2023) |
| "This study examines substance use disorder (SUD) treatment utilization patterns in response to a pandemic." | ( DeViva, J; Farook, M; Gross, G; Levina, V; Meshberg-Cohen, S, 2023) |
| "The research on substance use disorders is ongoing in the quest to find anti-addiction vaccines to treat drug abuse." | ( Bury, E; Cameriere, R; Cingolani, M; Ribeiro, ILA; Scendoni, R, 2022) |
| "Patients with substance use disorders (SUD) under methadone maintenance therapy (MMT) are susceptible to a number of complications (psychological and metabolic disorders)." | ( Abbaszadeh-Mashkani, S; Banafshe, HR; Boroumand, H; Dehkohneh, SG; Ghaderi, A; Hazegh, P; Mamsharifi, P; Matini, AH; Ostadmohammady, F; Padoei, F, 2023) |
| "Patients with substance use disorders (SUD) under methadone maintenance therapy (MMT) are susceptible to a number of complications (psychological and metabolic disorders)." | ( Abbaszadeh-Mashkani, S; Banafshe, HR; Boroumand, H; Dehkohneh, SG; Ghaderi, A; Hazegh, P; Mamsharifi, P; Matini, AH; Ostadmohammady, F; Padoei, F, 2023) |
| "Our findings indicate unmet substance use treatment needs due to the limited accessibility and heightened threshold for ED visits during the pandemic." | ( Kim, S; Kolla, NJ; Le Foll, B; Mondoux, SE; Rajack, N; Tardelli, VS, 2023) |
| "Co-occurrence of substance use disorder and mental illness complicates treatment and is associated with increased disability." | ( Drake, RE; Metcalfe, JD, 2023) |
| "Providing specialty treatment for drug abuse disorders will be increasingly important for healthcare administrators thanks to recent mental health parity legislation." | ( Duncan, DF; Ellis-Griffith, G; Nicholson, T; Nimkar, S, 2023) |
| "Two-thirds had a documented substance use disorder treatment need and 20 % demonstrated mental health treatment need." | ( Hartung, DM; Kempany, K; McCracken, CM; Nguyen, T; Waddell, EN, 2023) |
| "Outpatient substance use treatment services in Bordeaux, France." | ( Auriacombe, M; Baillet, E; Gauld, C; Kervran, C; Micoulaud-Franchi, JA; Serre, F, 2023) |
| "Many treatment-seeking individuals with substance use disorder who report medical cannabis use meet criteria for CUD, particularly those reporting concurrent recreational use." | ( Busse, JW; Costello, J; Mackillop, J; N S Gendy, M; Rush, B; Sousa, S; Taisir, R, 2023) |
| "Increasing access to mental health and substance use treatment may be critical for those residing in these remote locations." | ( Ali, R; Dohn, P; Dolezal, A; McFadden, L; Severson, M, 2023) |
| "Psychoactive substance use is associated with sleep characteristics and clinically relevant correlates in people with untreated OSA." | ( Baldassarri, SR; Blohowiak, RF; Byrne, S; Chu, JH; Deng, A; Kushida, C; Xu, Z; Yaggi, HK; Zinchuk, A, 2023) |
| "Treatment outcomes for individuals with substance use disorders (SUDs) are variable and more individualized approaches may be needed." | ( Kiluk, B; Kohler, R; Lichenstein, SD; Potenza, MN; Ye, F; Yip, SW, 2023) |
| "Medicaid is the largest payer of substance use disorder treatment in the US and plays a key role in responding to the opioid epidemic." | ( Abraham, AJ; Andrews, CM; Grogan, CM; Shoulders, A; Westlake, MA, 2023) |
| "People with substance use disorders (SUD) receive treatment and care in the community or residential treatment at Treatment and Rehabilitation Centers (TRCs) established by the Department of Health." | ( Baba, T; Harada, T; Kanamori, S; Nomura, K; Peralta, J; Rey, FI; Shirasaka, T; Takano, A; Villaroman, A, 2023) |
| "Schizophrenia and comorbid substance use disorders (SUDs) are associated with poor treatment outcomes but differences between the associations of different SUDs with clinical outcomes are poorly characterized." | ( Batra, G; Chan, KMY; Guruswamy, G; Ker, S; Kollins, SH; Palmer, EOC; Patel, R; Rentería, ME; Valko, M, 2023) |